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Abstract
The present study examined whether genetic polymorphisms on the estrogen receptor, 
androgen receptor, and serotonin transporter genes affect mood reactivity or mood 
variability in women. A total of 279 women from the university community completed a 
screening questionnaire (phase 1) for the study. During phase two, 146 women provided 
a buccal swab which was analyzed for Variable Number Tandem Repeat (VNTR) 
polymorphisms on the aforementioned genes. They also participated in an anxiety- 
inducing task. The Positive and Negative Affect Scale Expanded (PANAS-X), the 
Pleasantness-Unpleasantness Scale, as well as the Beck Anxiety Inventory (BAI) were 
completed prior to and following the completion of the mood induction task in order to 
assess mood reactivity. Mood variability was assessed in the third phase of the study 
where 62 women completed the PANAS and the Pleasantness-Unpleasantness Scale at 
eight one-hour intervals over the course of one 24-hour period. It was hypothesized that 
women’s mood variability, either during the laboratory mood manipulation or over the 8- 
hour period, would differ based on number of repeats of (1) the 17 base pair element 
within intron 2 of the Serotonin transporter gene (5-HTT), (2) CAG repeat numbers on 
the Androgen Receptor (AR) gene, or (3) number of TA repeats on the Estrogen Receptor 
a (ERa) gene. Women’s emotional variability did not differ significantly as a function of 
genotype. However, with respect to emotional reactivity, the following trends were 
observed: (1) a greater amount of overall mood change and PA change for the 
homozygous long group of the ERa allele, (2) a greater amount of NA change for the 
heterozygous group of the ERa allele, and (3) a greater amount of PA change for the 
8/10-9/10 allele group of the 5-HTT gene. Additional predictors of affect are discussed.
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Polymorphic Regions o f the Estrogen Receptor, Androgen Receptor and Serotonin 
Transporter Genes and their Association with Mood Variability in Young Women
The purpose of this study was to examine the effect of specific estrogenic, 
androgenic, and serotonergic gene repeats on mood variability in young women. There is 
much evidence that many mood and anxiety disorders are heritable (Middeldorp et al., 
2005) and thus, somehow linked to genetic factors. However, very little research has been 
conducted to determine which genes play crucial roles in regulating mood and mood 
variability. Such information could have important implications for women’s health. 
Particularly because affective disorders are nearly twice as prevalent in women than in 
men (APA, 2000). The detection of genetic predictors of mood variability would aid in 
the development of potential screening procedures that would allow for identification of 
women who are susceptible or genetically predisposed to mood and/or other affect 
disorders such as Depression, Bipolar Disorder, and Borderline Personality Disorder. It 
might also aid in the development of better pharmacological treatments. Previous 
research has linked mood with serotonin, estrogens, and androgens. The present study 
examined whether genes regulating these chemicals are linked to mood variability by 
examining a number of Variable Number Tandem Repeats (VNTRs). Specifically, the 
relationships between mood variability and the number of VNTRs on the estrogen 
receptor, androgen receptor, and serotonin transporter genes were investigated.
A tandem repeat is a short sequence of DNA that is repeated in a head-to-tail 
fashion at a specific chromosomal locus (Snustad & Simmons, 2000). Tandem repeats are 
interspersed throughout the human genome and the number of copies of each sequence 
present at a given site on a chromosome is highly variable. With regard to gene loci, one
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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VNTR region is inherited from each parent, making possible a number of allelic 
combinations. The polymorphic nature of VNTR regions therefore makes it possible to 
distinguish between individuals. When profiles of unrelated individuals are compared on 
a single VNTR locus, they are typically observed to be different. Though it is possible for 
two individuals to have the same genetic profile at one or two loci by chance, the 
likelihood of more than one person having the same DNA profile at four, five, or six 
different VNTR loci is extremely small. For example, when DNA profiles are used for 
forensic purposes, the match probability between unrelated people was estimated at 
less than 3x10 ' ' *  (using only a single multi-locus probe) and less than 5 x 10 *̂  (using 
two multi-locus probes) (Tamaki & Jefferies, 2005). These probabilities are so low that 
the only instance in which individuals would match on multiple loci would be in the case 
of monozygotic twins. Thus, individual differences in VNTRs may reflect phenotypic 
differences in specific traits and are worth examining in this context.
What follows is a review of the literature pertaining to the estrogen receptor gene, 
androgen receptor gene, and serotonin transporter gene as well as a description of how 
these genes may play a role in determining variability in affect. In addition, the role of 
the hormones associated with the aforementioned genes and their effects on abnormal 
psychological functioning will also be discussed. Finally, a short section will be 
presented on the current theoretical models of mood and affect, mood structure, and the 
various methods that have been employed in attempting to assess affective variability. 
Serotonin (5-HT)
Serotonin (5-HT) is a peptide neurotransmitter that is derived fiom the amino acid 
tryptophan and is converted to its final structure in a two step process that is
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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characterized first by hydroxylation, forming 5-hydroxytryptophan (5-HTP), and then by 
decarboxylation, resulting in the end product serotonin (Stryer, 1997). The final step in 
the conversion, or the decarboxylation, is performed by the enzyme dopa-decarboxylase 
which is also involved in the synthesis of dopamine and norepinephrine.
Originally studied as a vasoconstrictor in blood plasma, serotonin derives its name 
from the Latin word serum, meaning watery animal fluid; and tonic, a Greek word 
referring to that which is characterized by muscular tension (Palfai & Jankiewicz, 1997).
It was in 1953 that Twarog and Page first demonstrated the presence of 5-HT in the 
mammalian central nervous system, giving rise to the theory that 5-HT may play a role in 
regulating brain function (Cryan & Leonard, 2000). Indeed, research over the past few 
decades has demonstrated that decreased brain serotonin levels are associated with 
symptoms of major depression (e.g Nobler, Mann, & Sackeim, 1999). In fact, the 
serotonergic theory of depression has gained such prominence that it led Cowan (2002) to 
equate it with the status of “a textbook truism.”
Evidence for the biochemical theory of depression first came about when 
reserpine was given to patients to treat high blood pressure (see discussion by Palfai & 
Jankiewicz, 1997). Following administration of the drug, many of these patients became 
severely depressed. It was later revealed that reserpine depletes stores of monoamines, or 
peptide neurotransmitters, including dopamine (DA), serotonin (5-HT), and 
norepinephrine (NE).
In the mid 1970s, the rate limiting enzyme in the conversion of 5-HT from 
tryptophan (tryptophan hydroxylase) was inhibited using parachlorophenylalanine in 
remitted depressed patients taking the antidepressants imipramine and tranylcypromine
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(Marks, Marks, & Smith, 1996). These patients showed a rapid and robust return in 
depressive symptomatology which was reversed again relatively rapidly following 
cessation of the depletion exercise. Similarly, Delgado et al. (1990) depleted tryptophan, 
the amino acid precursor of 5-HT, using tryptophan-free diets and amino acid loading, in 
remitted depressed patients. He demonstrated a similar relapse into the depressive state in 
those patients who had previously responded to selective serotonin reuptake inhibitor 
(SSRI) treatment. The depressive symptoms were quickly reversed following 
replenishment of tryptophan stores.
Since the time of these studies, serotonin has been further implicated in the 
pathogenesis of affective disorders via experiments that have demonstrated the following: 
(a) reduced cerebrospinal fluid (CSF) concentrations of 5-hydroxyindoleacetic acid (5- 
HIAA), the major metabolite of 5-HT in drug-free depressed patients; (b) reduced 
concentrations of 5-HT in postmortem brain tissue of depressed and/or suicidal patients; 
(c) decreased plasma tryptophan concentrations in depressed patients and a profound 
relapse in remitted depressed patients who have responded to a serotonergic 
antidepressant when brain tryptophan availability is reduced; (d) in general, all clinically 
efficacious antidepressants augment 5-HT neurotransmission following chronic 
treatment; (e) clinically efficacious antidepressant action by all inhibitors of 5-HT uptake; 
(f) increases in the density of 5-HT2 binding sites in postmortem brain tissue of 
depressed patients and suicide victims, as well as in platelets of drug-free depressed 
patients; and (g) decreased number of 5-HT transporter binding sites in postmortem brain 
tissue of suicide victims and depressed patients and in platelets of drug-free depressed 
patients (see review by Owens & Nemeroff, 1994).
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As illustrated above, evidence of the role of serotonin in the development and 
maintenance of depression was bolstered considerably through the development of the 
SSRI family of antidepressants. SSRIs block the reuptake of serotonin by the vesicles in 
the pre-synaptic membrane and make the neurotransmitter available for a longer period of 
time at the synapse, thus relieving depressive symptoms (see discussion by Palfai & 
Janowicz, 1997). Perhaps the most commonly known SSRI is fluoxetine (Prozac).
Another class of antidepressants, known as monoamine oxidase inhibitors (MAOls) are 
sometimes used in the treatment of depression when SSRIs fail. MAOls work by binding 
irreversibly to monoamine oxidase (MAO) molecules, which are the molecules that 
typically break down serotonin in the central nervous system. Clearly, there is a great 
deal of evidence suggesting 5-HT plays a role in the development and maintenance of 
depression.
The Serotonin Transporter (5-HTT) and the Serotonin Transporter Gene
Given the link between serotonin and depression, a number of studies have 
examined whether the serotonin transporter (5-HTT) gene is involved in the pathogenesis 
of mood disorders. Located on chromosome 17ql l.l-17ql2 , the human 5-HTT gene 
spans 31 kilo-base pairs (kbp) and 14 exons (Ramamoorthy et al., 1993). A VNTR 
element of 17 bp (base pairs) has been identified in the second intron of the serotonin 
transporter gene (Lesch et ah, 1994).
The serotonin transporter (5-HTT) is associated with the presynaptic membrane of 
the 5-HT neuron and regulates 5-HT neurotransmission through reuptake and removal of 
released 5-HT in the synaptic cleft (Rudnick & Clark, 1993). Although the precise 
mechanism is unclear, the serotonin transporter has been suggested to be involved in
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mood disorders (Owens & Nemeroff, 1994). Experiential effects combined with 
differences in primary protein structure could potentially change the function of the 
protein and consequently affect such characteristics as binding affinity, thereby creating a 
vulnerability to dysfunctional affective processes..
Several studies have identified the serotonin transporter as a significant factor 
when attempting to differentiate between clinical and non-clinical mood disordered 
populations. One of the most prominent differences has been found in the level of activity 
of the transporter itself. Ichimiya et al. (1992) examined whether 5-HTT binding was 
altered in patients with mood disorders using positron emission tomography (PET). 
Thirteen antidepressant-naive patients with mood disorders, and 21 age-matched healthy 
control subjects participated in this study. The clinical group was composed of seven 
individuals with major depressive disorder and six individuals with bipolar disorder. PET 
scans were performed using a selective ligand for 5-HTT. The uptake was quantified in 
the thalamus and midbrain by graphical method with reference tissue, and binding 
potential was used for the index of 5-HTT binding. Binding potential in the thalamus 
was significantly increased in patients with tnood disorders as compared to control 
subjects, whereas binding potential in the midbrain did not differ between the groups. 
Subgroup comparison showed that patients with major depressive disorder had 
significantly higher binding potential in the thalamus compared to control subjects. 
Binding potential in the thalamus was higher by approximately 22% in the combined 
patients and 23% in MDD patients relative to control subjects. These findings suggest 
that higher 5-HTT binding potential, particularly in the thalamus, may be a factor in the 
development and maintenance of mood disorders.
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In 1996, Ogilvie and colleagues set out to identify polymorphisms of the 5-HTT 
gene to find out whether there was a relationship between specific polymorphisms and 
the occurrence of affective disorders. Patients with major affective disorder were 
recruited from inpatient and outpatient programs from the Royal Edinburgh Hospital in 
Scotland. A total of 83 patients were used in the experimental group. Of these 83 patients, 
39 had single or recurrent major depressive episodes and 44 had bipolar disorder. The 
control group consisted of 122 anonymous blood donors and 71 volunteers who had been 
screened for psychiatric disorders. Three alleles of the 17 bp VNTR region in intron two 
of the 5-HTT gene were detected (STin2.9, STin2.10, and STin2.12) containing 9, 10 and 
12 copies of the allele respectively. The frequencies of the different forms of the allele in 
the control group were compared with those in the affective disorders group. The STin2.9 
allele frequencies were significantly higher among individuals in the affective disorders 
group than among individuals in the control group. When the experimental group was 
further separated into unipolar and bipolar groups and each was compared to the control 
group, it was found that a significantly higher proportion of the unipolar group had 
genotypes containing the STin2.9 allele.
Similar to the above study, an examination of whether the 5-HTT gene is linked 
to anxiety disorders was conducted by Ohara et al. (1999). The subjects were 103 patients 
who had met the Diagnostic and Statistical Manual o f  Mental Disorders (DSM-IV) 
criteria for anxiety disorders and 106 healthy control subjects. The results indicated that 
there was a significant difference between the anxiety disorder group and the control 
group in the proportion of participants carrying the STin2.12 allele (12 repeats in intron 2 
of the human 5-HTT gene) in that the frequency of the STin2.12 allele in the patient
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group was significantly higher than in the control group. That is, patients diagnosed with 
obsessive compulsive disorder (OCD) and generalized anxiety disorder (GAD) had 
significantly higher proportions of the STin2.12 than did controls, and patients with a 
family history of either OCD or GAD tended to have the STin2.12 allele in higher 
numbers than did controls (Ohara et ah, 1999). There was not a statistical difference 
according to gender.
Based on the research of Ogilvie et al. (1996) and Ohara et al. (1999), further 
investigation seems warranted on the frequency of VNTR polymorphisms within intron 2 
of the serotonin transporter gene (5-HTT) and how these regions relate to mood and 
mood variability.
In addition to studies directly examining the 16/17 bp VNTR on the 5HTT gene, 
it has also been shown that human 5-HTT gene transcription is modulated by a common 
polymorphism in its upstream regulatory region. Lesch et al. (1996) reported a 
polymorphism in the transcriptional control region 1 kilo-base upstream of the 5-HTT 
coding sequence. This region is known as the 5-HTTPLR and it is composed of 16 repeat 
elements. The polymorphism consists of a 44 base pair insertion or deletion usually 
within repeat elements 6 to 8. Initial experiments demonstrated that the long (insertion) 
and short (deletion) variants of the 5-HTT gene-linked polymorphic region (5-HTTPLR) 
have different transcriptional efficiencies. The short (s) variant of the polymorphism 
reduces the transcriptional efficiency of the 5-HTT gene promoter, resulting in decreased 
5-HTT expression and 5-HT uptake in lymphoblasts. Lesch and colleagues discovered 
that the basal activity of the long variant (1) of the gene promoter is more than twice that 
of the short variant of the promoter. Interestingly, uptake of serotonin in cells
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homozygous for the long form of the promoter polymorphism was approximately two 
times that in cells carrying one or two copies of the short variant of the allele (Lesch et 
al., 1996). These results led to the hypothesis that clinical populations afflicted by 
disorders of the depression-anxiety spectrum should exhibit either the homozygous s/s or 
the heterozygous s/1 genotype.
This hypothesis was recently confirmed in a Hungarian study which employed 
139 unrelated Caucasian females as participants (Gonda et al., 2006). The women in the 
study presented with the absence of a history of current or lifetime Axis I psychiatric 
disorders. Using the Temperament Measure (TEMPS-A), which measures affective 
temperaments on five scales (depressive, cyclothymic, hyperthymic, irritable, and 
anxious), a significant association was found between the short (s) allele and the TEMPS 
scores of the depressive, anxious, irritable, and particularly the cyclothymic 
temperaments; no such association emerged however with respect to the hyperthymic 
temperament.
A German group (Hoefgen et al., 2005) set out to replicate the findings of the 
Lesch et al. (1996) study with the goal o f employing a larger sample size that was 
ethnically homogeneous and systematically obtained and screened. A total of 466 patients 
diagnosed with Major Depressive Disorder (MDD) were recruited from consecutive 
admissions to the Department of Psychiatry at the University of Bonn in Germany. All 
participants necessitated inpatient hospitalization and met either DSMIII-R or DSM-IV 
criteria for MDD. A total of 836 control subjects were randomly recruited from the list of 
registered inhabitants of the city with the support of the local Census Bureau of the City 
of Bonn. Patients and control subjects were all of German descent, the criteria of which
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was met when both parents and all four grandparents originated from Germany. Results 
indicated that the short allele of 5-HTTLPR was significantly more frequent in patients 
(45.5%) than in control subjects (39.9%). Taken together, the results of the above three 
studies suggest that the short allele of the 5-HTTPLR is implicated in psychological 
dysfunction within the depression/anxiety spectrum and should be a strong candidate for 
future research.
Estrogen and the Estrogen Receptor Gene
Affective disorders are more prevalent in women than in men. MDD is the most 
commonly diagnosed psychiatric disorder among adults with U.S. lifetime prevalence 
rates o f 20 to 25% for women and 9 to 12% for men; point prevalence rates are 
approximately 6% and 3% for women and men respectively (American Psychiatric 
Association, 2000). Thus, in terms of MDD there appears to be a sex bias in that rates of 
MDD in women are approximately twice those of men.
Although the reason for this gender difference is most likely due to a combination 
of biological, social, and environmental factors, it has been suggested that estrogen may 
play a key role in this phenomenon (Steiner, Dunn, & Bom, 2003). For example, women 
are known to experience depressive episodes at times of hormonal change in their 
reproductive years. Affective disorders such as premenstrual syndrome, postnatal 
depression, and post-menopausal depression are all associated with low serum levels of 
estrogen (see review by Pearlstein, Rosen, & Stone, 1997). Furthermore, hormone 
replacement therapy has been shown to alleviate symptoms of postnatal and post 
menopausal depression (Best, Rees, Barlow, & Cowen, 1992). Thus, estrogen maybe 
involved in the sex difference in rates of depression.
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Given the link between estrogen and antidepressant effects, the estrogen receptor 
may play a role in mood change. The estrogen receptor (ER) consists of two subtypes: a 
and p, both of which are expressed predominately in limbic-related areas (Osterlund & 
Hurd, 2001). The ERa receptors are found primarily in the hippocampus and the 
amygdala (Osterlund & Hurd, 2001), two areas of the brain that are linked to mood and 
aggression, respectively. In comparison to ERa expression, ERP mRNA expression is 
low and generally not detectable in several nuclei of the human amygdala (Osterlund & 
Hurd, 2001). The amygdaya therefore appears to be ERa dominant, suggesting that it is 
the a receptor that modulates neurons involved in emotional, affective and motivational 
behaviours mediated by the amygdala.
Research on the ERa gene indicates that specific polymorphisms of the TA 
(Thymine- Adenine) repeat may be associated with a number of mood variables. To test 
the potential contribution of genetic variations in this hormone receptor to anxiety. 
Comings, Muhleman, Johnson, and MacMurray (1999) examined the association between 
the alleles of the TA repeat on the ER a gene and the nine subscales and total score of the 
Symptom Checklist-90 (SCL-90) in a group of 179 adult males treated for substance 
abuse. The alleles were divided into two groups: short (s) and long (1). Alleles ranged 
from 179 base pairs to 213 base pairs. Short alleles included repeats 2 to 12 and long 
alleles included repeats 13 to 19. Analysis of the s/s, 1/s, and 1/1 genotypes showed a 
significant association of the long alleles with three of the SCL-90 scores: anxiety, phobic 
anxiety, and total symptoms as measured by the global severity index. Of these, the 
anxiety score remained significant. There was a progressive decrease in the mean anxiety
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score from the 1/1 genotype, the s/1 genotype, to the s/s genotype. It was determined that 
the ER a gene accounted for 7% of the variance of the anxiety score.
Similar to the Comings et al. (1999) study, Westberg et al. (2003) investigated the 
repeat polymorphism in the ERa gene in 172 42-year-old women who had been assessed 
using the Karolinska Scales of Personality (KSP). As with the Comings et al. (1999) 
study, the alleles were divided into two groups according to base pair numbers.
Seventeen alleles were found for the ERa gene, ranging from 183 to 215 base pairs. 
Alleles falling beneath 191 base pairs were classified as short while alleles corresponding 
to 191 base pairs and over were classified as long. In order to elucidate the possible 
influence of the ER alpha gene on the different aspects of personality as measured by 
means of the KSP, the possible associations between this gene and four different factors 
(neuroticism, psychoticism, non-conformity, and extraversion) were examined. Initially, 
neuroticism, psychoticism, and non-conformity all appeared to be associated with the 
short allele of the ER a gene. However, after correction for multiple comparisons, the 
associations with the non-conformity factor (including the indirect aggression and 
irritability subscales), as well as the psychoticism factor (including the suspicion 
subscale), remained significant. Thus, short alleles on the ERa gene may be associate 
with non-conformity and psychoticism.
The two studies on the ER a gene thus suggest that longer alleles seem to be 
associated with anxiety in men (Comings et al., 1999) but shorter alleles are associated 
with neuroticism, suspicion, irritability, and verbal aggression in women (Westburg et al., 
2003). These findings suggest that a smaller number of TA repeats on the estrogen 
receptor a gene may be a predictor of mood variability in women.
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A ndrogens and the Androgen Receptor
Like estrogen, the androgens are a group of steroid hormones derived from 
cholesterol. The principle androgens, in order of increasing potency, include 
dehydroepiandosterone (DHEA), dehydroepiandosterone sulfate (DHEAS), 
androstenedione, and testosterone (Davison & Davis, 2003). Testosterone is the most 
commonly referred to androgen and is responsible for the development of secondary sex 
characteristic in males. The actions of androgens in women remains unclear, however, 
with the body of research literature focusing primarily on their role in female sexual 
functioning and libido (Cameron & Braunstein, 2004). There is increasing evidence for 
widespread distribution of androgen receptors in women in areas such as breast, bone, 
and brain (Davison & Davis, 2003). This widespread distribution of receptors indicates 
that androgens and their metabolites may have important roles in pathologies such as 
breast cancer, osteoporosis, and even cognitive decline (Davsion & Davis, 2003).
In 2002, a group of international experts convened in New Jersey and formed the 
Princeton Consensus Statement on the definition, classification, and assessment of 
Androgen Insufficiency Syndrome in women (Cameron & Braunstein, 2004). This 
session was spawned by the need to clarify the ambiguous role of androgens in women’s 
health. Bolstered by a substantial review of all the current literature, the Princeton 
Consensus Statement outlines a number of symptoms, both physiological and 
psychological, thought to be characteristic of androgen insufficiency syndrome. These 
include a diminished sense of well being or dysphoric mood; persistent unexplained 
fatigue; and sexual function changes, including decreased libido, sexual receptivity, and 
pleasure (Bachmann et al., 2002).
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The number of CAG repeats on the Androgen Receptor (AR) gene is believed to 
reflect activity of the AR gene, with lower repeat numbers reflecting higher gene 
activation. Evidence of this comes from a study conducted by Chamberlain, Driver, and 
Miesfield (1994) whereby the CAG tract in both humans and rats was eliminated in vitro, 
resulting in increased transcription of the AR gene.
Recent research suggests that the CAG repeat may play a role in depression. Two 
studies have found relationships between CAG repeat number and depression in men 
(Harkonen et al., 2003; Seidman, Araujo, Roose, & Mikinlay, 2001). Harkonen and 
colleagues (2003) found that CAG repeat number was positively correlated with 
depression, as expressed by the wish to be dead (r = .45;p  < .0001), depressed mood 
(r = .23; p = .003), anxiety (r = 0.15; p  < 0.05), and deterioration of general well-being 
(r = .22; p = .004). These results suggest that low AR gene activation (e.g., high repeat 
numbers) is associated with depression. Although this research was conducted using male 
participants, CAG repeat number may also play a role in depression and mood variability 
in women.
Mood Versus Affect
As highlighted by Oinonen and Mazmanian (2002, p. 230), “mood and affect are 
closely related terms that are often used interchangeably in the literature.” They are able 
to make the point however, that these two terms and their associated characteristics are 
actually different levels of similar constructs. The American Psychiatric Association 
describes affect as a pattern of observable behaviours that is the expression of a 
subjectively experienced feeling state or emotion (APA, 2003). Examples listed include 
sadness, elation and anger. This is in contrast to mood, which is described as a more
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pervasive and sustained emotional state. Mood is likened to climate, while affect or 
emotion is likened to fluctuating changes in weather within that climate. For example, 
whereas a full emotion of anger might last for only a few minutes, an annoyed irritable 
mood might last for hours or days. The semantics surrounding these constructs can cause 
confusion. Even in the literature, the term mood is often used to subsume all affective and 
emotional states. However, they are in fact different concepts. For the purposes of this 
project, the terms “affect” and “emotion” will be used interchangeably.
In summarizing his own findings, Watson, in collaboration with Vaidya (2003) 
describes how mood differs from affect in three important respects. First, mood research 
focuses almost exclusively on subjective phenomenal experience, while affect or 
emotions have traditionally been viewed as multi-modal psycho-physiological systems, 
with at least four distinct components: (1) subjectivity (e.g., feelings of fear and/or 
apprehension), (2) the physiological (e.g., activation of the sympathetic nervous system), 
(3) the expressive (e.g., the facial expression of fear) and (4) the behavioural (e.g., flight 
away from danger) (Watson & Vaidya, 2003). Mood measurement, in contrast, typically 
involves only the assessment of subjective feelings (component 1), without consideration 
of the other three components. Second, affect or emotions, as already described by the 
APA, tend to be brief, lasting perhaps only a few seconds. Third, and finally, the concept 
of mood subsumes all subjective feeling states, not simply those experiences that 
accompany classical prototypical emotions such as fear and anger (Watson & Vaidya, 
2003).
In a review of the literature, Larsen (2000) highlights another three important 
ways in which mood differs from affect. Moods, he states, are thought to differ from
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emotions in both duration and intensity. Moods generally last longer than emotions, with 
some moods going on for hours, days, or weeks; while emotions tend to be shorter lived, 
but more intense. The author states that moods will nag at us, but emotions will scream at 
us. It is also argued that moods and emotions differ with regard to their course and how 
they unfold. Emotions typically have a distinct onset and offset in time, with a peak in 
between, whereas moods typically build gradually, such that it is difficult to say when 
they begin or end. This is because emotions often have a distinct cause or object of 
reference. With moods however, a causal incident or event is not always identifiable. The 
third and perhaps most compelling way in which moods differ from emotions is through 
the information that they convey (e.g., emotions generally produce immediate effects on 
the autonomic nervous system).
Much of the time, mood, as examined in the context of the psychological and 
medical literature, is examined primarily for the purpose of identifying disturbances 
outside of the normal range. Thus, clinical research is typically interested in describing 
the poles of a spectrum of mood that range from depression to mania. Far less research 
has focused on affect and how it varies in those whose mood does not deviate outside of 
the normal range. For example, an area of research that has been largely ignored is the 
examination of individual differences in affect variability. Research investigating 
individual differences in mood fluctuations throughout the day is important, as individual 
differences in these variations may help us understand underlying mechanisms involved 
in affect regulation. This will help our understanding and treatment of mood disorders.
The regulation of affect is central to being able to function in society on a daily 
basis. At the most basic fundamental level, the regulation of affect is critical to success
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in the workplace, at home, or while attending school. Those who are incapable of 
emotional regulation would likely exhibit a wide range of interpersonal difficulties that 
may eventually come to interfere with basic task accomplishment and the development of 
competencies in several areas. For one whose affect has a tendency to fluctuate greatly, 
it would be very difficult to maintain relationships involving friends, colleagues, and 
even family. Not only would it be a challenge for such an individual to sustain current 
relationships, it would also be difficult to develop and maintain fulfilling relationships 
with new people. Thus, research on individual differences in affective variability and 
affect regulation is important.
Measurement o f Affect
Early mood research tended to emphasize the importance of discrete specific 
types o f affect such as fear-anxiety, sadness-depression, anger-hostility and happiness- 
joy (McNair, Lorr, & Droppleman, 1971). This approach was favored because structural 
analyses of mood terms repeatedly identified well-defined content factors corresponding 
to these specific affective states. Moreover, a common core of discrete affects including 
fear, sadness, and anger emerged consistently across factor analyses, reflecting different 
pools of items (Watson & Clark, 1994).
The problem with this approach lies in the fact that measures of different specific 
affects are strongly interrelated and tend to show questionable discriminant validity 
(Watson & Vaidya, 2003). In other words, correlations among similar affects tend to be 
quite strong. For example, those who experience significant levels of one type of 
negative affect (e.g., anger) tend to report elevated levels of other types of negative 
affects (e.g., fear, sadness, and guilt). Similarly, individuals who report one type of
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positive affect, also tend to indicate higher levels of other types of positive affect. Thus, 
an individual who reports being joyful may also endorse items indicating energy, 
enthusiasm, or interest. Multi-trait multi-method analyses can therefore be said to 
demonstrate strong evidence for non-specificity in these affective states, or strong 
positive correlations among similarly valenced affects. This is in contrast to specificity 
which would indicate a unique relationship between items examining the same target 
affect.
Dimensional models of affect have been most prevalent over the past two decades 
with models proposed by both Russell (1980) and Watson and Tellegen (1985). Each 
model proposes that mood exists along a two dimensional circumplex. In each of the 
circumplex models, mood descriptors are represented along the outside of a circle. In the 
model presented by Russell, the circumplex is presented as four bipolar dimensions that 
are spaced 45 degrees apart: Pleasantness (pleasure vs. misery). Excitement (excitement 
vs. depression). Activation (arousal vs. sleepiness) and Distress (distress vs. 
contentment). Russell (1980) suggested that these interrelationships could be represented 
by a spatial model in which affective concepts fall in a circle in the following order; 
pleasure (0°), excitement (45°), arousal (90°), distress (135°), displeasure (180°), 
depression (225°), sleepiness (270°), and relaxation (315°).
Using a greater amount of self report data, Watson and Tellegen (1985) put forth 
their own circumplex model. Similar to the model of Russell (1980), their circumplex 
presented four bipolar dimensions that were also spaced 45 degrees apart, but with 
differing labels on the poles. The poles of Watson and Tellegen are instead labeled: 
Pleasantness (happy vs. sad). Positive Affect (excited vs. sluggish). Engagement (aroused
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vs. still) and Negative Affect (distressed vs. relaxed). What is noteworthy about this 
model is the fact that Positive and Negative Affect each occupy their own dimension and 
that they are not simply on opposite ends of the same spectrum. According to Tellegen 
(1985), Positive Affect and Negative Affect are preferable dimensions to arousal and 
pleasantness-unpleasantness, in part because they relate more directly to major 
personality factors (Hepburn & Eysenck, 1989). Perhaps one of the most noteworthy 
aspects regarding the theoretical approach of Tellegen is the parallel illustrated between 
the two-dimensional mood space formed by Positive Affect and Negative Affect and the 
two-dimensional personality space formed between neuroticism and extraversion. 
(Hepburn & Eysenck, 1989; Tellegen, 1985). Specifically, Tellegen (1985) proposed that 
extraversion predicts positive affect, whereas neuroticism predicts negative affect. In a 
study where participants completed three mood questionnaires a day each weekday for 
three weeks, Hepburn and Eysenck (1989) found that mean positive affect levels were 
best predicted by extraversion, but that mean negative affect was strongly related to 
neuroticism. Interestingly, affective variability was related to both personality factors 
with neurotic extraverts exhibiting the most variability and stable introverts having the 
least mood variability.
Watson and Tellegen (1985) have further proposed that general dimensions (e.g., 
positive and negative affect) and discrete affects (e.g., anger, fear, and joy) are not 
mutually exclusive, but rather, reflect different levels of a single integrated hierarchical 
scheme. This means that the higher order dimensions of negative affect and positive 
affect can each be broken down into several correlated yet distinct affective states. For 
example, the dimension of negative affect can be decomposed into such specific negative
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affective states such as fear, hostility, and sadness. The hierarchical scheme that is 
hypothesized proposes that the specific content of the mood descriptors (such as fear, 
hostility and anger as described above) exists at the lower levels. These include labels 
that describe distinctive qualities of the individual discrete affects. This is in contrast to 
the upper level of the hierarchy (e.g., negative affect or positive affect) which is said to 
reflect the valence of the descriptors -  that is whether they reflect positive or negative 
affective states.
Watson and Clark (1992) published a paper supporting the existence of such a 
hierarchical arrangement of affect for negative affect. They conducted four independent 
studies examining the relationships among fear, hostility, sadness, and guilt through a 
series of multi-trait, multi-method matrices. Consistent with a hierarchical model, all four 
negative affects showed significant convergent validity and adequate discriminate 
validity, indicating that they represent meaningful and differentiable psychological 
constructs.
Studies Measuring Affect
While numerous studies have examined day-to-day affect over three or four week 
periods (e.g., Oinonen and Mazmanian, 2001), only a few studies have examined 
variability in affect during the course of the day. Clark and Watson (1988) conducted a 
study to assess the relationship between common events and two independent mood 
factors: positive affect and negative affect. A sample of 18 upper-class psychology 
students was recruited for the study. Participants were asked to record their moods three 
times a day (morning, afternoon, and evening) for 90 days. Subjects rated themselves on 
57 mood terms using a five-point scale ranging from 1 {applies very little or not at all) to
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5 {applies very much). In addition to the affect terms, each affect rating form contained 
six items querying subjects’ daily experiences. Daily experiences were broken down into 
six categories including physical health problems, any drugs they had taken including 
alcoholic beverages, any notable experiences or events, things that were on their mind, 
number of hours they had slept the night before, and for females, whether they were 
experiencing their menstrual period. Positive affect was found to be associated with a 
wide range of daily events, whereas fewer correlations were found between these events 
and negative affect. The relation between high PA and reported social interactions 
(particularly physically active social events) was especially robust whereas the 
correlation between NA and physical problems was especially strong.
In another study examining the relationship between daily events and mood, 
Kennedy-Moore, Greenburg, Newman, and Stone (1992) examined the determinants of 
daily affect variability. Ninety-four subjects completed a mood diary every 15 minutes 
for one day, and subjects’ emotions, activities, and locations were assessed. Although it 
did not contain a validated measurement tool (such as the PANAS or the Mood Adjective 
Checklist), the diary was designed to assess the psychosocial environment of the 
participants and consisted of a sheet divided into five sections, one of which examined 
affect. The first section asked for the time of day and physical position (sitting, standing, 
or reclining). The second section asked participants to indicate their location using 
response options (e.g., home, office, commuting). The third section gave participants 29 
options to select with regard to current activities. The 29 options could be further divided 
into three categories consisting of physical, mental/social, and non-work. Participants 
could check multiple activities, however, the three most taxing were coded. A fourth
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checklist was used for characterizing the social environment. The fifth and final section 
asked subjects to indicate their emotion by selecting an adjective from a list. It is not 
specified how these adjectives were derived or what methodology was used to select 
them. The adjectives used to assess affect consisted of the following: neutral, annoyed, 
angry, anxious, bored, excited, happy, rushed, sad, tense, tired, and stressed. The 
presence of linear trends suggested that mood increased or decreased throughout the day, 
partially as a function of activity and location. Negative linear trends were found for 
“annoyed, anxious, and rushed” indicating that as the day progressed, the occurrence of 
these moods decreased. The opposite was the case for positive moods in that their 
prevalence tended to increase as the day progressed. Despite not using a validated tool to 
measure affect, this study is noteworthy in that it is one of the few to examine change in 
affect within one day and to examine predictors of this change.
In a study conducted in Germany, Peters, Nicolson, Berkhof, Delespaul, and De 
Vries (2003) used experience sampling methodology (ESM) to investigate changes in NA 
and PA following minor daily events in those with MDD compared with healthy 
participants. The study was conducted because, although it is known that MDD is 
characterized by high negative affect (NA) and low positive affect (PA), little is known 
about emotional reactivity in daily life for individuals with MDD. ESM was used to 
collect data from participants at selected moments during their daily activities. 
Participants received auditory signals (beeps) from a wristwatch programmed to emit 10 
beeps between 7:30 a.m. and 10:30 p.m. each day, at semi-random intervals of 
approximately 90 minutes. After receiving a beep, participants completed self-report 
forms concerning current mood, negative and positive events, and their appraisals.
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Participants completed ESM reports for six consecutive days, including a weekend. 
Momentary mood states were assessed with 16 adjectives rated on 7-point scales ranging 
from 1 {not at all) to 7 {very). Two eight-item scales derived from a factor analysis were 
used to measure positive and negative affect. The items anxious, irritated, restless, tense, 
guilty, irritable, easily distracted, and agitated were averaged to form a NA scale; while 
the items energetic, enthusiastic, happy, cheerful, talkative, strong, satisfied, and self- 
assured were averaged to form a PA scale. The results showed that contrary to 
expectation, MDD participants did not report more frequent negative events, although 
they did report fewer positive events. Further analysis revealed that both NA and PA 
responses to negative events were blunted in the MDD group, whereas responses to 
positive events were enhanced. NA responses to negative events persisted longer in MDD 
participants. Depressed participants with a positive family history or a longer current 
depressive episode showed relatively greater NA response to negative events.
At least three studies have examined changes in affect throughout the course of 
one day. None of those studies have reported individual difference predictors of low 
versus high affect variability throughout the day. Furthermore, no previous studies have 
examined genetic predictors of individual differences in predisposition to low or high 
affective or emotional reactivity.
Affect Induction Procedures (AIPs)
One method used to explore individual differences in predisposition to affective 
reactivity involves inducing a positive or negative mood in participants and then 
examining predictors of low versus high emotional reactivity. In a review of nearly 250 
studies spanning a ten-year period, Gerrards-Hesse, Spies, and Kordelia (1994) have
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classified all mood or emotional induction procedures (MIPs) into five distinct categories. 
The first category of MIP is that which employs the free mental generation of emotional 
states. Included in this category is hypnosis and imagination. In the case of the hypnosis 
MIP, subjects enter a deep trance and then are instructed to remember and imagine a 
certain situation of their own choice in which they felt happy or sad. In studies working 
with the imagination MIP, subjects are instructed to imagine and re-experience situations 
or events in order to evoke the intended mood.
The second category of MIP is that which is based on the guided mental 
generation of emotional states. Included in this category are film and story MIPs, as well 
as music MIPs. For example, experimenters will typically present a story or a short 
description of a situation to their subjects and instruct them to imagine the situation and 
“get involved” in the feelings suggested. In the case of the MIPs involving music, 
subjects listen to a mood-suggestive piece of classical or modem music and are instructed 
to try to get into the mood expressed by the music using whatever means they find most 
effective.
The third category is much like the second except that participants are not 
instracted to try to put themselves in a mood that is congment with the story or film. It is 
assumed that the participants’ mood will change based on the emotional quality of the 
material being presented. This category of MIP is known as the presentation of emotion 
inducing material.
Category four is represented by MIPs that are related to the presentation of need- 
related emotional situations. Therefore procedures expose subjects to situations activating 
certain needs, such as the need for achievement or affiliation. An example is the
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success/failure MIP, which relates the need for achievement. For example, in such a 
procedure participants may be given false-positive or false-negative feedback concerning 
their performance in a test alleged mainly to assess cognitive abilities.
The fifth and final category deals with MIPs aiming at the generation of 
emotionally relevant physiological states. This type of MIP typically involves the 
systematic variation of physiological states, usually in combination with a variation of 
situational stimuli to influence mood states. For example, to induce physiological arousal, 
studies applying the drug MIP use a drug (e.g., epinephrine), or a placebo introduced to 
subjects as a mood-inducing drug. Similar to this are the MIPs employing the facial 
feedback hypothesis which hypothesizes that facial expressions influence mood state. 
Accordingly, experimenters using the Facial Expression MIP instruct subjects to contract 
and relax different muscles to produce a frown or a smile, thereby inducing a negative or 
positive emotional state.
Previous research has not examined whether any genes are predictive of 
individual differences in response to MIPs. The present study employed an MIP that 
contained elements of both categories three and four. Participants were told that they 
would be given a test o f their intelligence, and then the Mental Rotations Test 
(Vandenberg, 1971) was administered. The goal of this MIP was to attempt to induce a 
mood state characterized by anxiety, stress, or unpleasantness. It has been shown that 
tasks that are presented to participants relating to intelligence are generally believed to 
induce anxiety associated with evaluation and performance (Mogg, Matthews, Bird, & 
MacGreggor -Morris, 1990). Thus, In addition to activating the need for achievement, 
this MIP would also place the participant in a self perceived success/failure situation. It
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was hoped that a situation that purported to assess their three-dimensional intellectual 
capacity would be especially stressful, inducing either anxiety or an increase in negative 
affect.
The Present Study
One hundred and forty-six women participated in the present study examining 
whether emotional variability and reactivity differ as a function of specific genetic 
polymorphisms. DNA samples were obtained in order to determine the number of VNTR 
polymorphisms on estrogen, androgen, and serotonin transporter genes. Women were 
then subject to an in vivo mood induction anxiety-producing task that was preceded and 
followed by the completion of an affective rating scales. Following the mood induction, 
women were asked to complete eight consecutive hourly mood surveys over the course of 
one eight-hour period. The focus was to examine the relationships between number of 
VNTR repeats on three specific genes and emotional and mood variability on two tasks.
Our hypotheses were threefold in this study. It was hypothesized that emotional 
variability and/or reactivity as measured using the “m vzvo” laboratory mood 
manipulation and self-report affect measures would differ among the women according to 
genotype. Specifically it was hypothesized that numbers of: (1) 9 or 12 repeats in a 
VNTR polymorphism of a 17 base pair length element within intron 2 of the Serotonin 
transporter gene (5-HTT), (2) CAG repeat numbers on the Androgen Receptor (AR) 
gene, and/or (3) TA repeats on the Estrogen Receptor a  (ERa) gene, would be significant 
predictors of emotional reactivity and/or emotional variability in women.




Two-hundred-and-seventy-nine women (mean age = 19.60 years, SD = 2.40) from 
I.,akehead University and the Thunder Bay community were recruited to participate in a 
study investigating Genetic Factors Affecting Women’s Health. This study received 
approval by the Lakehead University Research Ethics Board. The majority of participants 
were students from introductory and upper year psychology courses. Those in 
introductory psychology received one bonus point of course credit for participation in the 
screening phase of the study. If participants met the criteria necessary to participate in 
additional phases of the study, they were eligible to receive up to two additional bonus 
points (one per phase).
Based on information provided by the screening questionnaire, 146 women (mean 
age = 19.63 years, SD = 2.40) were selected for the laboratory phase of the study (phase 
2). These women were representative of three different groups: (1) Mood Change Group 
(n -  49). This group consisted of 23 previous oral contraceptive (OC) users who reported 
OC-related negative mood change and 26 current OC users who report previous or 
current negative mood change while taking OCs. (2) No Mood Change Group {n = 43). 
This group consisted of 26 current OC users and 17 previous OC users who reported no 
history of OC-related mood change. (3) Control Group (n = 54). The control group was 
comprised of women who had never taken hormonal contraceptives. The above groups 
were selected for methodological reasons relevant to a larger study (Oinonen, 2006). 
However, this type of sample likely included women who are particularly vulnerable to 
hormonal mood effects (i.e., the mood change group). This should increase the likelihood
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of finding a relationship between mood variability and VNTRs on hormonal genes, if  
these genes do affect emotional variability. Of most relevance to the general population, 
however, may be the results from the control group, as these women were randomly 
selected based on their status as never-users of hormonal contraceptives.
A total of 62 women (mean age = 19.76, SD = 2.90) participated in phase three of 
the study, the hourly mood rating phase. The only exclusionary criterion used was the 
ongoing use of medication that could affect mood (e.g., antidepressants or sedative- 
hypnotics). These participants were excluded as such medications cause exogenous 
effects on mood and could produce a blunting effect in their affective response, which 
would subsequently have affected variability in the hourly mood surveys. This was an 
important exclusionary criterion given that the purpose of the hourly mood rating phase 
was to examine genetic predictors of daily affective/emotional fluctuation.
Measures
Screening Questionnaire (SQ). The screening questionnaire (SQ) (see Appendix 
A) includes several different sections. The screening questionnaire was used to select 
participants based on the three groups described above. It included six sections including 
demographics, reproductive history, contraceptive history, medical and health history, 
psychiatric history, eating habits, and personality/mood. Many of the questions were 
taken from the questionnaires developed for Oinonen’s two previous projects on 
hormonal effects, as reliability and validity statistics were available. The demographic 
section included questions relating to age, education, relationship status, and ethnicity. 
Questions about reproductive history included information about age of menarche, parity, 
length of menstrual cycle, length of menses, premenstrual symptoms, and cycle regularity
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(both before and during hormonal contraceptive use). The section on contraception 
contained questions about sexual activity, contraceptive history, reasons for specific 
contraceptive choices, types of OCs taken, reasons for discontinuing specific 
contraceptives, duration of contraceptive use, and specific questions about the experience 
of certain OC side effects, including positive and negative mood change. The medical 
and health history questions included information regarding medical and hormonal 
conditions, medication use, alcohol and drug use, smoking status, and family history of 
hormonal medical conditions (e.g., thyroid disorders, diabetes, breast cancer) or fertility 
problems. A section on personal and family psychiatric history contained questions about 
postpartum depression, schizophrenia, alcoholism, unipolar depression, and bipolar 
disorder. Finally, scales from four questionnaires were included to collect information 
about mood, personality, eating habits, and sociosexuality. These included the Depression 
Scale from the Symptom Checklist 90-Revised (SCL-90) (Derogatis, 1994), the PANAS 
(Watson, Clark & Tellegen, 1988), the Neuroticism and Extraversion Scales fi-om the 
Revised NEO Personality Inventory (NEO-PI-R; Costa & McRae, 1992), the Eating 
Disorders Inventory (Gamer, 1991) and the Sociosexual Orientation Inventory (SOI) 
(Simpson & Gangestad, 1991). The latter two scales are not relevant to the present study. 
The personality section of the SQ assessed the participants’ tendency toward neuroticism 
and extraversion, two dimensions of personality that have been found to correlate highly 
with mood (Egloff, 1998). These characteristics were assessed using the NEO-PI R. It 
was estimated that the questionnaire would take approximately 45 minutes to complete.
Mental Rotations Test (MRT) Anxiety Induction Paradigm. In order to examine 
individual differences in mood reactivity, an anxiety induction paradigm was employed.
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Participants were told they would be completing an intelligence test and were then given 
the Mental Rotations Test. Mood/affect ratings were completed both before and after the 
mood induction to assess any change in affective states. The Vandenberg (1971) 
adaptation of Shepard and Metzler’s (1971) mental rotations test (see Appendix B) is a 
measure of visuospatial ability that involves mentally rotating a target three-dimensional 
shape and matching it to other three-dimensional shapes. The participant is required to 
choose which two of four drawings (presented as possible answer choices) depict the 
target drawing in a rotated position. The test consists of two sections, each containing ten 
items, making the total number of items twenty. Each item consists of a criterion figure, 
two correct alternatives, and two “distracter” items. The correct alternatives are 
structurally identical to the criterion but are shown in a rotated position. For half of the 
items, the distracters are rotated mirror-images of the criterion while distracters for the 
other half of the items are rotated images of one or two of the other structures. In total, 
there are 40 correct responses. Standard test instructions were employed. However, 
given that the test was used for the purpose of inducing an anxious state, participants 
were initially told they would be timed and their responses later scored. Prior to 
beginning the MRT, participants were given approximately two- and -a-half minutes to 
complete three sample problems, which were provided for the purpose of allowing 
participants the opportunity to familiarize themselves with the format of questions on the 
test. Following the completion of the three sample problems, the women were given 
three minutes to complete each of the two parts (10 items each). Thus, total testing time 
was six minutes. As the test consists of 20 questions, and each question has two correct 
answers, the test was scored out of 40 possible points. Participants were allotted one point
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for each correct answer they selected. For the MRT, Vandenberg and Kuse (1971) report 
adequate Kuder-Richardson-20 internal consistency (.88), test-retest reliability (.83), and 
split-half reliability corrected by the Spearman-Brown formula (.79).
Laboratory Mood Questionnaires. Two similar questionnaires were used to assess 
mood reactivity in the laboratory session. One questionnaire was administered prior to 
the completion of the mental rotation test (MRT) anxiety induction paradigm and the 
second questionnaire was completed after the MRT. The first questiormaire was entitled 
the Pre-MRT Questionnaire (see Appendix C). It consisted of three individual tests; the 
Beck Anxiety Inventory (BAI) (Beck, 1990), the Pleasantness-Unpleasantness Scale 
(Diener, Larsen, Levine, & Emmons, 1985), and the Positive-Negative Affect Scale 
Expanded (PANAS-X) (Watson & Clark, 1994) (see below for a description of these 
scales). The second questionnaire administered to participants was entitled the Post-MRT 
Questionnaire (see Appendix D). This test also contained the BAI, the Pleasantness- 
Unpleasantness Scale, and the PANAS-X. In addition, the Post-MRT Questionnaire 
contained specific questions asking the participants how well they thought they 
performed on the test and what percentage of items they thought they answered correctly 
on the test.
Beck Anxiety Inventory (BAI). The BAI measures the severity of self-reported 
anxiety (Beck, 1990). It consists of 21 descriptive anxiety symptoms which are rated on 
a four-point scale with the following correspondence; 0 (not at all), 1 {mildly, it did not 
bother me much), 2 {moderately, it was very unpleasant, but I  could stand it), and 3 
{severely; I  could barely stand it). The 21 items include numbness or tingling, feeling hot, 
wobbliness in legs, unable to relax, fear o f  the worst happening, dizzy or light headed.
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heart pounding or racing, unsteady, terrified, nervous, feelings o f choking, hands 
trembling, shaky, fear o f  losing control, difficulty breathing, fear o f dying, scared, 
indigestion or discomfort in abdomen, faint, face flushed, and sweating (not due to heat). 
Analysis has revealed that the BAI correlates highly with other measures of anxiety, 
including the Hamilton Anxiety Scale Revised (r = .51) and the anxiety subscale of the 
Cognition Check List (CCL-A) (r = .51) (Beck, Epstein, Brown, & Steer, 1988). The 
BAI was constructed to measure symptoms of anxiety that are minimally shared with 
those of depression (Beck & Steer, 1990). With their diagnostically mixed sample of 160 
outpatients. Beck, Epstein, Brown, and Steer (1988) reported that the BAI had a high 
internal consistency (Cronbach coefficient alpha = .92). This same study reported a test 
retest reliability of .75.
Pleasantness-Unpleasantness Scale. The second mood measure on both of the 
Laboratory Mood Questionnaires assessed the pleasantness component of positive affect. 
The pleasantness scale contained the words happy, joyful, content, at ease, and calm 
(Diener et al., 1985). Conversely, the unpleasantness scale contained the words sad, 
blue, downhearted, alone, and lonely (Diener et al., 1985). Participants were asked to 
indicate how they felt at the moment they were completing the surveys. They rated each 
adjective on a five- point likert-type response scale which was anchored by the values I 
{very slightly or not at all), and 5 {extremely).
Positive and Negative Affect Scale Expanded (PANAS-X). The PANAS-X is an 
expansion of the original PANAS that attempts to identify the higher order dimensions of 
Positive Affect (PA) and Negative Affect (NA). To assess these specific emotional 
states, Watson and Clark (1994) created a 60-item expanded version of the PANAS. In
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addition to the two original higher order scales (PA and NA), the PANAS-X measures 11 
specific affects; fear, sadness, guilt, hostility, shyness, fatigue, surprise, joviality, self- 
assurance, attentiveness, and serenity. The PANAS-X thus provides for mood 
measurement at two different levels. Internal consistency reliabilities (Cronbach’s 
coefficient alpha) for both scales are high, generally ranging from .83 to .90 for Positive 
Affect, and from .85 to .90 for Negative Affect. Test retest reliability indicates that scores 
on all of the scales are quite stable, with coefficients ranging from .51 (for Serenity) to 
.71 (for general Negative Affect in the larger sample) (Watson & Clark, 1994). The 
stability coefficients based on general instructions are consistently higher than those 
based on “past week” instructions, which further validates the use of different time 
instructions with the PANAS-X scales. The PANAS-X was completed in the laboratory 
both before and after the mental rotations test anxiety induction paradigm (along with the 
other two mood measures).
Hourly Mood Questionnaire. The Hourly Mood Questionnaire (see Appendix E) 
is a take home questionnaire that participants completed eight times over the course of 
one eight-hour period. The questionnaires were completed approximately one hour apart. 
The questionnaire was designed with the intention of monitoring daily mood variability.
It consisted of the Positive and Negative Affective Scale (PANAS) (see below) and the 
Pleasantness-Unpleasantness questionnaire (see above). The first seven questionnaires 
given to the participants were identical. The final questionnaire, in addition to consisting 
o f the PANAS and the Pleasantness-Unpleasanfress questionnaire, also contained several 
additional questions (see Appendix F). The questions inquired as to whether anything 
occurred during the course of the day that may have affected their mood; how many
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hours of sleep they acquired the night before; and whether or not they exercised, took any 
drugs or medications, drank alcohol, or drank coffee.
Positive and Negative Affect Scale (PANAS). The PANAS (Watson, Clark, & 
Tellegen, 1988) consists of two scales: one for positive affect (PA) and one for negative 
affect (NA). High positive affect reflects a state of high energy, full concentration, and 
pleasurable engagement; whereas low PA is characterized by sadness and lethargy. In 
contrast, NA is a general dimension of subjective distress and unpleasant mood states, 
including anger, contempt, and disgust. Low NA indicates a sense of calm and security. 
The PA PANAS items include attentive, interested, alert, excited, enthusiastic, inspired, 
proud, determined, strong, and active, while the PANAS scale for NA includes the items 
distressed, upset, guilty, scared, hostile, irritable, ashamed, nervous, jittery, and afraid.
In the current study, participants were asked to indicate how they felt at the moment they 
were completing the surveys. They were asked to rate each adjective on a five-point 
response scale ranging from 1 (very slightly or not at all) to 5 (extremely). The PANAS 
was also used in the take home phase of the study in which participants were required to 
complete an affect survey at eight intervals during one 24-hour period.
Genotyping. The DNA samples were genotyped in the Paleo-DNA Laboratory at 
Lakehead University under the supervision of Dr. Carney Matheson. For the purposes of 
tliis study, genomic DNA was isolated from the buccal tissue using the chelex extraction 
method which has been shown to be as efficient or more efficient than using proteinase K 
and phenol-chloroform extraction (Walsh, Metzger, & Higuchi., 1991). The following 
three different repeat regions were quantified: CAG repeats on the androgen receptor 
(AR) gene, TA repeats on the estrogen receptor a (ERa) gene, and the 16/17 base pair
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Polymorphic Regions 42
repeat in the serotonin transporter (5-HTT) gene. The different regions were 
subsequently amplified by polymerase chain reaction (PCR) using fluorescently labeled 
primers. The fluorescently labeled DNA fragments were analyzed by size with automated 
capillary electrophoresis using an ABI 3100 Automated Sequencer (Applied Biosystems) 
and analyzed using genescan software. This method provided measures of the number of 
repeats at each polymorphic region for both alleles for each participant.
Procedure
Screening Phase. In the screening phase of the project, women were recruited 
from Lakehead University and the surrounding community of Thunder Bay. Recruitment 
was primarily targeted at undergraduate psychology classes. The women were asked to 
participate in a study on genetic factors in women’s health. All participants completed 
Consent Form A (see Appendix G), a Screening Questionnaire, and received Debriefing 
Form A (see Appendix H). Based on information obtained from the screening 
questionnaires, three groups of women were selected; (1) Mood Change Group, (2) No 
Mood Change Group, and (3) Control Group (as discussed above). Each woman deemed 
appropriate for the subsequent laboratory phase was contacted by telephone. The 
telephone call was used to convey the requirements of the next stage of the study, and 
also to determine whether the women were interested in participating. If the participant 
indicated interest, an appointment for a laboratory session was then scheduled.
Laboratory Phase. Each laboratory session lasted approximately 35 minutes and 
involved the completion of consent form B (Appendix I); the collection of a DNA sample 
by buccal swab, the measurement of height, weight and finger lengths; the counting of 
digit hairs (for the larger study); and completion of the ‘in vivo’ mood manipulation task.
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Buccal swabs of DNA were collected by having the research assistant rotate a collection 
swab on the inside of each woman’s cheek. Once collected, the swab was dried at room 
temperature, placed in a plastic bag, and then stored in a freezer set to -34 degrees 
Celsius.
With regard to body measurements, a fixed tape measure was used to measure 
height and a digital scale was used to measure weight. Mitutoyo Electronic Digital 
calipers (Model MIT-500-171) were employed in the measurement of the length of digits 
2 to 5. Both left- and right-sided traits were measured twice to reduce measurement error 
and to assess test-retest reliability. Each digit on both the left and right hands was 
measured on its ventral surface from the basal crease to the tip, using the electronic 
digital calipers measuring to 0.01 mm. These measurements have shown a high degree of 
test-retest reliability (Manning et ah, 1998). The number of hairs on the back of the 
second phalanges of each digit were also counted, as these digits are differentially 
sensitive to testosterone and hair number appears to be an indicator of individual 
differences in testosterone sensitivity or exposure (Maiming, 2002). All of the body 
measurements were collected for the purposes of the larger study.
Upon entering the lab, the buccal DNA swab and the body measurements of the 
participants were taken. Following the collection of body measurements, participants 
were asked to complete the first Laboratory Questionnaire or the Pre-MRT test. Then the 
mood induction procedure was initiated. Participants were presented with the Mental 
Rotations Test and they were instructed that they would be completing a brief test which 
would assess their level of intelligence. They then completed the MRT. The intention of 
the instructions used with the MRT test was to induce a negative or anxious mood state in
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participants which could be measured by examining the change between the Pre-MRT 
and Post- MRT Test affect scores. After completion of the MRT, participants completed 
the Post- MRT laboratory Questionnaire. Following the administration of the Post MRT 
questionnaire, women received a full debriefing about the mood induction procedure and 
further information about the experiment. They were also provided with Debriefing Form 
B (see Appendix J) which explained the purpose of the study and also provided a listing 
of various mental health resources within the community. In addition, participants were 
given the opportunity to complete Consent Form D (see Appendix M) which involved 
providing consent to allow the experimenters to contact them for a possible follow-up 
study within the next five years (if such a project receives ethical approval by the 
Research Ethics Board).
Hourly Mood Ratings. After participants received Debriefing Form B, they were 
asked whether they would like to participate in the third and final stage of the study. 
Those interested in participating received Consent Form C (see Appendix K). Participants 
were asked to complete the Hourly Mood Questionnaire once every hour for eight 
consecutive hours. They were instructed to complete these questionnaires as soon as 
possible after the laboratory phase. The women were provided with two packages of the 
eight questionnaires. The second package acted as a spare in case they were unable to 
complete the first as instructed. They were also provided with a summary of the 
instructions (see Appendix E) indicating that if  they failed to complete the assessment in 
one day, they could simply start a new assessment the next day using the extra materials. 
The Hourly Mood Questionnaire was used to indicate the amount of variability in 
participant affect over the course of an eight hour period. When complete, participants
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returned their questionnaires to the lab where they were provided with Debriefing Form 
C (see Appendix L) and a description of the entire study.
Genetic Analyses
Extraction. Genomic DNA was isolated fi-om the buccal tissue using a Chelex 
extraction method (Walsh et ah, 1991). A 10% Chelex solution was added to each 
sample, after which samples were incubated at 56 degrees Celsius and mixed at 500 rpm 
for approximately 3 hours.
Amplification. Amplification was achieved via polymerase chain reaction (PCR). 
To a 2.0 pL sample of genomic DNA the following solutions were added: 5.0 pL PCR 
buffer, 2.0 pL dNTP’s, 0.5 pL each of forward and reverse primers, 1.5 pL MgC12, 0.2 
pL polymerase, and 38.3 pL H20 to a total of 50.0 pL. Samples were then transferred to 
the Eppendorf Mastercycler for a Hot Start at 94°C for 3 minutes. The conditions for 45 
cycles consisted of dénaturation at 94°C for 1.5 minutes, annealing at 57.7°C for 1 
minute, and extension at 72°C for 2 minutes. Final extension occurred at 60°C for 1 hour, 
at which point samples were held at 4°C until sequencing.
Genetic Analysis. To each amplified sample 0.3 pi of size standard and 9 pi of Hi- 
Di Formamide were added. Samples were then denatured at 95°C for 3 minutes and then 
immediately chilled on crushed ice for 2 minutes. The labeled DNA fragments were 
analyzed by size using automated capillary electrophoresis using an ABI 3100 
Automated Sequencer (Applied Biosystems) and analyzed using the Genescan software. 
This measured the number of repeats at each polymorphic region for both alleles for each 
participant.
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Data Reduction and Statistical Analyses
The analyses consisted of six multivariate analyses of variance (MANOVAs) with 
follow-up univariate ANOVAs to determine whether women differed in mood variability 
or reactivity based on the Androgen Receptor (AR) gene, the Estrogen Receptor a gene 
(ERa), or the Serotonin Transporter Gene (5HTT). Each MANOVA included genotype 
group (from one gene region) as the independent variable. The dependent variables were 
Overall Mood Change, Overall Positive Affect Change, and Overall Negative Affect 
Change for the laboratory emotional reactivity analyses; and Positive Affect Variability, 
Negative Affect Variability, Pleasantness Variability, and Unpleasantness Variability for 
the hourly affect variability analyses. For the AR and ERa genes, genotype groups were 
determined by performing a median split based on the frequency of the number of repeats 
for each allele. For these genes, alleles with repeat numbers falling beneath the median 
were labeled as short(s), while those falling above the median were labeled as long (1). As 
the genotype of each gene of each participant includes two alleles, a median split of the 
data resulted in three allelic combinations: homozygous short (s/s), heterozygous (s/1), 
and homozygous long (1/1). For the AR genotype, CAG repeats corresponding to < 244 
base pairs were categorized as short, while those that corresponded to > 245 base pairs, 
were categorized as long. For the ERa gene, TA repeats that corresponded to < 191 base 
pairs were categorized as short, while those that corresponded to > 192 base pairs were 
categorized as long. Genotypes containing both a short and long allele were heterozygous 
and those that were either short/short and long/long were termed homozygous.
The five 5HTT genotype groups were based on actual genotype: 8/10, 9/10,
10/10, 10/12 and 12/12. Because the 8/10 and 9/10 groups contained few participants (n
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- 1 and n = 3 respectively), they were combined to form one group. Thus, the two 
MANOVAs conducted with 5HTT genotype as the independent variable, employed four 
groups (actual genotype) within the independent variable rather than three (e.g., s/s, s/1 or 
1/1).
The seven dependant variables were measures of emotional reactivity that were 
obtained in the laboratory, and measures of affect variability determined from the hourly 
mood surveys. Overall Lab Mood Change was calculated by transforming the absolute 
values of the pre-post difference scores from the eleven scales of the PANAS-X into z 
scores and then adding them together. Positive and Negative affect change within the lab 
was determined by subtracting pre-administration PANAS scores from post­
administration PANAS scores. For the hourly mood survey variables, a score was derived 
for each hour that a survey was completed. Thus, at the end of the take home exercise, 
each of Positive Affect, Negative Affect, Pleasantness, and Unpleasantness had eight 
scores, one for each hour. Variability for each of these four DVs was determined by 
grouping all eight scores for one variable together and calculating the variance. 
MANOVAs were then performed using the ERa, AR, and 5HTT genotypes as 
independent variables and laboratory affect change scores and hourly mood rating 
variability scores as dependent variables.
Results
Data screening
Prior to the main analyses, the distributions of the three laboratory dependent 
variables (DVs) (Overall Lab Mood Change, Lab Positive Affect Change, and Lab
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Negative Affect Change) and the four DVs from the take-home exercise (Hourly Positive 
Affect Varibility, Hourly Negative Affect Variability, Hourly Pleasantness Variability, 
and Hourly Unpleasantness Variability) were examined as a function of genotype group 
for the presence of univariate and multivariate outliers (e.g., Tabachnick & Fidell, 2001).
Using the criteria of > | 3.29 | (e.g., Tabachnick & Fidell, 2001), one univariate 
outlier was found for Lab Negative Affect Change for the homozygous long allele group 
on the AR gene. Another outlier was found in the heterozygous allele group for Negative 
Affect Variability on the same gene. A logarithmic transformation of negative affect 
variability was consequently employed to decrease the influence of outliers in the AR 
gene analysis.
Two univariate outliers were found for the ERa gene distribution of scores, each 
within the heterozygous allelic group. The first outlier was found for the Lab Negative 
Affect Change distribution and the second outlier was found for the Overall Lab Mood 
Change distribution. These outliers were dealt with using logarithmic transformations.
For the 5HTT gene, an additional two univariate outliers were found. The first 
outlier was found in the 10/10 genotype group within the Lab Negative Affect Change 
distribution, and the second was found in the 12/12 genotype group within the Overall 
Lab Mood Change distribution of scores. As was the case with the outliers found on the 
other genes, these distributions were outlier-free following a logarithmic transformation.
Following screening for univariate outliers, Mahalanobis distances {p < .001 
criterion) were used to screen for multivariate outliers. For the purposes of this screening 
exercise, the three measures of affect variability obtained from the laboratory session 
(Overall Lab Mood Change, Change in Lab Positive Affect, Change in Lab Negative
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Affect) were examined together and the four affect variables obtained from the take home 
exercise (Hourly Positive Affect Variability, Hourly Negative Affect Variability, Hourly 
Pleasantness Variability, and Hourly Unpleasantness Variability) were examined. 
Distances were calculated across variables for each genotype group within each gene for 
both sets of variables. Analyses revealed only one multivariate outlier which 
corresponded to participant number 141 within the heterozygous genotype group of the 
AR gene for the laboratory group of variables. It was decided that this individual would 
be deleted from the MANOVA examining the effect of AR genotype on laboratory affect 
change.
Assessing Multivariate Assumptions
Before undertaking analyses to test the main hypotheses, the data were examined 
to ensure that the assumptions of MANOVA were met. Graphical checks of linearity 
using bivariate scatterplots indicated that linearity was adequate for all dependent 
variables. Criteria for normality included passing a visual check of the distribution of 
scores as well as using the following formulas: [(skewness standard error of skewness) 
< 3] and [(kurtosis standard error of kurtosis) < 3]. The assumption of normality was 
judged adequate for all distributions.
Box’s M multivariate test for homogeneity of variance-covariance matrices found 
adequate homogeneity of variance-covariance matrices for the first three analyses using 
genotypes on the AR, ERa, or 5HTT genes as the independent variable (IV), and 
variables from the laboratory anxiety induction procedure as DVs. Box’s M results for 
these anxiety induction lab analyses variables were adequate: F  (12, 16525) = 1.08,/? > 
.05, for AR genotype; F  (12, 5358) = 1.54,/? >.05. for ERa genotype; and F  (18, 500) =
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0, 64, p  >.05 for the 5HTT gene. All three MANOVAs using the variables from the take 
home hourly mood ratings as IVs and genotype as DVs produced significant values for 
the Box’s M test, (p < .001) indicating heterogeneity of variance-covariance matrices. 
Examination of cell sample sizes and cell variances and covariances indicated that 
smaller sample sizes were sometimes associated with larger variances. This suggests the 
possibility that significance tests may be liberal (Tabachnick & Fidell, 2001).
For the purposes of examining multicolinearity, correlations between the seven 
dependent variables are listed in Table 1. With regard to the three variables assessed in 
the laboratory anxiety induction procedure. Overall Lab Mood Change was found to be 
negatively correlated with Lab Positive Affect Change, indicting that greater lab mood 
change was associated with a decrease in PA. With regard to the variables assessed in the 
take home hourly affect ratings, significant positive correlations were found between 
Positive Affect Variability and Pleasantness Variability, and Negative Affect Variability 
and Unpleasantness Variability. The relationships between these dependent variables 
have not been examined in previous research and are of interest here. Due to both the 
robustness of MANOVA to correlations below .90 (Tabachnich & Fidell, 2001) and the 
relevance of these correlations to the current study, multicollinearity was not judged to be 
a problem and no adjustments were made to the variables.
The following statistics and statistical criteria were used for the analyses. For each 
of the three sets of main analyses, MANOVAs were performed on the affect scores using 
an alpha level of .025. Significant MANOVAs were followed up with univariate 
ANOVAs. The conservative Pillai’s criterion for evaluating multivariate significance
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was used in all analyses. Using an alpha level of .025, Tukey’s Honestly Significant 
Difference (HSD) post hoc comparisons were conducted on any significant effects. 
Manipulation Check for the Anxiety Induction Procedure
In order to asses whether the laboratory anxiety induction procedure was 
effective, a paired samples Mest was conducted comparing pre-and post-anxiety- 
induction BAI scores. The t-test revealed that the anxiety-induction procedure was indeed 
effective, with the mean level of anxiety having increased from the pre-test (M = 5.41, SD 
= 4.70) to the post-test {M= 6.05, SD = 5.20), t(121) = -2.29, p  = .02.
Allele Frequencies
The number and frequency of each allele for the three gene regions are reported in 
table 2 (see Table 2). For the AR CAG repeat region, repeats 21, 23, 19 and 25 are most 
fi-equent. This distribution of allele frequencies is comparable to other reports in the 
literature, though the range of repeats in the Harkonen et al. (2003) and Seidman et al. 
(2001) studies was greater than that of the present study, extending slightly beyond the 
highest number of repeats that was found in the present study. For the ERa TA repeat 
region, repeats 14 and 15 were most common. Similar frequencies were reported by both 
Comings et al. (1999) and Westburg et al. (2003). For the 16/17 5-HTT base-pair repeat 
region, repeats 10 and 12 were most frequent. Consistent with previous research, repeat 9 
occurred very infrequently (1.85%). Of particular interest, however, is the discovery of 
one allele with the 8 repeat. This is the first report of this short 8 repeat allele.
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Table 2
Allele Frequencies for the Androgen Receptor (AR), Estrogen Receptor a (ERa), and Serotonin 
Transporter (5HTT) Genes
Gene Repeat Base Pairs Repeat Numbers Frequency
1. AR CAG
2. ERa TA
192 4 1 0.45
221 14 1 0.45
227 16 3 1.32
230 17 2 1.35
233 18 16 7.46
236 19 24 10.09
239 20 16 7.46
242 21 46 20.18
245 22 21 9.21
247.5 23 28 1228
250 24 20 8.77
253 25 23 10.09
256 26 15 &58
259 27 6 2.63
261 28 2 0.90
264 29 1 0.45
267 30 1 0.45
180 12 3 1.80
182 13 3 1.35
184 14 25 11.26
186 15 94 42.34
188 16 21 9.01
190 17 9 4.05
192 18 7 3.15
194 19 2 0.90
196 20 5 225
198 21 4 1.80
200 22 21 9.46
202 23 12 5.41
204 24 11 4.95
206 25 4 1.80
212 28 1 0.45
(Table 2 continues)
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Table 2 (continued)
Allele Frequencies for the Androgen Receptor (AR), Estrogen Receptor a (ERa), and Serotonin 
Transporter (5HTT) Genes
Gene Repeat Alleles (Repeat Numbers) Frequency
3.5HTT 16/17 bp 228 8 1 0.46
244 9 4 1.85
261 10 85 39.51
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Main Analyses
Between Group Comparisons for the Laboratory Emotional Reactivity Variables
Three one-way between-subjects MANOVAs were performed on three dependent 
variables reflecting affect change as a result of the laboratory anxiety induction paradigm: 
Overall Lab Mood Change, Change in Lab Positive Affect, and Change in Lab Negative 
Affect. The independent variable for each analysis was the genotype of participants on 
one of either: the AR gene, the ERa gene, or the 5HTT gene.
For the MANOVA comparing the three AR genotypes, the means and standard 
deviations of the three mood change variables are listed in Table 3 (see Table 3). Using 
Pillai’s criterion, it was found that the three dependent variables were not significantly 
affected by AR genotype, F(6, 202) = 0.50,/? = .81, = .02, power = .13. Thus, when
the three laboratory mood variables were combined, mood reactivity was found not to 
differ as a function of AR genotype.
The means and standard deviations for the three lab affect change variables as a 
function of ERa genotype are listed in the top panel of Table 4 (see Table 4). The 
MANOVA comparing the three ERa genotypes found a strong trend indicating that the 
three genotypes differed in emotional reactivity, F(6, 144) = 2.43,/? = .029, = .09,
power = .81. Thus, a follow-up univariate ANOVA was computed on each dependent 
variable. No significant group differences were found with respect to any of the 
dependent variables. However, strong trends for the ERa genotype were exhibited for all 
three dependent variables. Among the strongest trends were those for Lab PA change.
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Means and Standard Deviations fo r  the Emotional Reactivity Variables in the Lab 







Mean (SD) Mean (SD) Mean (SD)
Lab Mood Change 0.88 (4.70) -0.82 (5.60) 1.03 (6.65)
Lab PA Change -3.28 (3.66) -3.15 (3.13) -3.63 (3.51)
Log Lab NA Change 1.39 (0.05) 1.40 (0.04) 1.40 (0.05)
Repeats falling at 244 base pairs and below are coded as short (s), while those falling at 
245 base pairs and above are coded as long (1).
*p < .025
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7‘ahle 4
Means and Standard Deviations for the Emotional Reactivity Variables in the Lab 




{n -  20)
1/1 genotype 
(« = 12)
Mean (SD) Mean (SD) Mean (SD)
Log Lab Mood Change' 1.40 (0.10) 1.36 (0.07) 1.44 (0.08)
I,ab PA Change' -3.70 (3.39) -2.05 (2.95) -4.83 (3.34)
Log Lab NA Change 1.39 (0.05) 1.41 (0.04) 1.37 (0.07)




Mean (SD) Mean (SD)
Log Lab Mood Change' 1.40 (0.10) 1.36 (0.07)
Lab PA Change' -3.95 (3.35) -2.05 (2.95)
Log Lab NA Change' 1.38 (0.05) 1.41 (0.04)
Repeats falling at 191 base pairs and below are coded as short (s), while those falling at 
192 base pairs and above are coded as long (1).
*/? < .025, "p < .07.
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f  \2,73) = 3.08,/? = 05, = .078, power = .58, and Overall Lab mood change F(2,73) =
2.77, p  = .069, r f’ = .07, power = .53. The trend for lab NA change was not as robust 
F(2,73) = 2.70, p  =.07, r f  = .07, power = .52. Tukey HSD post hoc tests revealed trends 
indicating less overall lab affect change for the s/1 group when compared with the 1/1 
group g(df = 73) = 0.08, p = .06, as well as less change in lab PA for the s/1 group when 
compared to the 1/1 group g(df = 73) = 2.78, p = .06. With respect to lab NA change, there 
was no evidence of any trends indicating group differences between the s/s and the 1/1 
group for any of the dependant variables. These results suggest that individuals 
homozygous for the long ERa alleles experienced more overall affect change and a 
greater decrease in PA in anxiety arousing situations than women with the short/long 
heterozygous alleles.
The above results and the direction of the means suggest that women possessing a 
heterozygous ERa genotype differ in affect reactivity from those with homozygous 
genotypes following an anxiety induction procedure. Therefore, further exploratory 
analyses were performed. A MANOVA was performed in which the two homozygous 
groups were combined and compared with the heterozygous group on the three emotional 
variables measured in the lab (see group means in the bottom panel of Table 4). The 
MANOVA indicated an overall group effect, F{3, 72) = 4.04,/? = .01, r\  ̂-  .14, power = 
.82. Follow-up one-way ANOVAs were conducted for each of the three dependent 
variables. A strong trend suggested that homozygotes exhibited a greater change in PA 
following the AIP than the heterozygotes, F  (1, 74) = 5.00, p  = .03, = .06, power = .60
The direction of this change was in a negative direction indicating homozygotes 
experience more of a decline in PA following anxiety arousing situations. Scores for
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Negative Affect change indicated that those with heterozygous alleles exhibited a greater 
change in negative affect as a result of the anxiety induction procedure, F (l, 74) = 4.48,/? 
= .04, r\  ̂= .06, power = .55. In other words, this result suggests that those with 
heterozygous (s/1) alleles on the AR gene may be prone to increases in negative affect in 
the face of threatening or anxiety provoking situations. A weaker trend was found for 
Overall Lab Mood Change Scores as homozygotes experienced more overall change in 
affect following the anxiety inducing procedure, F  (1, 74) = 3.66,/? = .06, r|^ = .05, power 
= .47. Thus, foliÂ jnVig the AIP, there were trends for homozygotes to show greater mood 
change, a greater decrease in PA, and less of an increase in NA compared to 
heterozygotes.
Means and standard deviations for the mood reactivity variables within each of 
the 5HTT genotypes are presented in Table 5 (see Table 5). Results for the MANOVA on 
the three dependant variables were similar to those of the AR gene, indicating no 
significant group differences in affect change across the four genotypes, F{9, 285) = 0.98, 
/? = .45, r|^ = .030, power = .38. Although this result was not significant, the direction of 
the means suggested the possibility of group differences for PA. Thus, follow-up 
ANOVAs were conducted for exploratory purposes. Those revealed a trend indicating 
group differences in lab positive affect change, F(3, 95) = 2.65,/? = .053 r f  = .08, power 
= .52. Thus, women with either the 8/10 or 9/10 genotype exhibited an increase in 
positive affect while those with all other genotypes exhibited a decrease in positive affect 
following the anxiety induction procedure. Despite the small sample size for the 8/10 and 
9/10 group, Tukey HSD post hoc tests revealed trends indicating that women with the 
8/10 or 9/10 genotypes differed form the other three genotypes in terms of PA change.
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10/10, g(95) = 4.33,p  = .072; 12/10 q{95) = 4.24,p  = .087; 12/12 g(95) = 4.65,p  = .035. 
Although based on a small sample, these results suggest that those possessing either the 
8/10 or 9/10 genotype may differ from the other genotypes in susceptibility to positive 
affect change.
Between Group Analyses for the Eight Hour Affect Variability Scores
In order to test hypotheses relating to daily affect variability, three one-way 
between-subjects MANOVAs were performed on the four dependent variables derived 
from the take home hourly affect ratings: Hourly Positive Affect Variability, Hourly 
Negative Affect Variability, Hourly Pleasantness Variability, and Hourly Unpleasantness 
Variability. Once again, the independent variable for each analysis was the genotype of 
participants on the AR gene, the ERa gene, or the 5HTT gene.
Means and standard deviations for the four hourly affect ratings variables as a 
function of AR genotype are reported in Table 6 (see Table 6). The MANOVA indicated 
that the four dependent variables were not significantly affected by AR genotype, F(8,
88) = 0.88,/? = .54, = .07, power = .28. Thus, when affect variability scores from the
hourly mood rating exercise were compared across AR genotypes, there was no 
significant difference in change in affect variability across the four measures.
Means and standard deviations for the four hourly affect rating variables as a 
function of ERa genotype are reported in Table 7. Despite a pattern in the means 
suggesting that the homozygous 1/1 genotype was associated with greater affect 
variability, the four dependant affect variability variables did not differ significantly 
according to ERa genotype, F(8, 60) = .47,/? = .87, r f  = .06, power = .20. Heterogeneity 
of variance-covariance matrices cannot account for the lack of a significant group
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Table 6








Mean (SD) Mean (SD) Mean (SD)
Log Affcct Variability 0.38 (0.35) 0.69 (0.47) 0.77 (0.48)
Positive Affect Variability 34.36 (19.63) 43.31 (36.81) 58.82 (103.72)
Pleasantness Variability 9.95 (8.71) 13.49 (13.81) 19.25 (24.95)
Unpleasantness Variability 0.37 (0.81) 3.61 (5.50) 3.11 (5.89)
Repeats falling at 244 base pairs and below are coded as short (s), while those falling at 245 base 
pairs and above are coded as long (1).
*/? < .025
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Table 7








Mean (SD) Mean (SD) Mean (SD)
Negative Affect Variability 7 27 (10.76) 7.86 (9.04) 10.59 (18.60)
Positive Affect Variability 44.33 (39.76) 35.24 (31.63) 71.95 (119.23)
Pleasantness Variability 13.28 (15.51) 11.99 (11.52) 27.12 (27.71)
Unpleasantness Variability 2.50 (3.99) 3.43 (5.70) 3.59 (6.80)
Repeats falling at 191 base pairs and below are coded as short (s), while those falling at 192 base pairs 
and above are coded as long (1).
*/? < .025
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difference as smaller sample sizes were associated with larger variances, indicating a 
liberal significance test and that null hypotheses can be retained with confidence 
(Tabachnick & Fidell, 2001).
Means and standard deviations for the four hourly affect ratings variables as a 
function of 5-HTT genotype are reported in Table 8. The MANOVA was not significant, 
F(12, 129) = 0.15, p  = .70, = .07, power = .31. These results indicate that affective
variability measured over an eight hour period does not differ with respect to AR, ERa, 
or 5HTT genotype in women.
Supplementary Analyses
Given that very little research has examined predictors of affect variability, two 
sets of supplemental analyses were conducted to further investigate the potential 
relationships between affect variability and both genetic and hormonal indicators. Chi- 
square analyses were used to examine the relationships between affect variability and 
genetic variables for three dichotomous variables. Spearman correlations were used to 
investigate any potential relationships between affect variability and some continuous 
hormonal variables.
For both sets of analyses, variables used to represent affective change/variability 
were: Overall Lab Mood Change, Daily Positive Affect Variability, and Daily Negative 
Affect Variability. For the chi-square analyses, these variables were each split into low 
and high groups based on a median split of the total affect change or variance scores. 
Thus, those participants exhibiting a small change in overall mood in the laboratory or a 
minimal amount of variability in daily PA or daily NA were classified as the low 
affective variability group within their respective variable, while those with a greater
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(« = 3) (n = 11) («=13) (« = 21)
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Negative Affect Variability 4.55 (7.32) 6.83 (5.17) 6.77 (12.80) 7.99 (13.42)
Positive Affect Variability 41.12 (37.38) 43.33 (32.94) 68.50 (86.69) 30.01 (16.07)
Pleasantness Variability 16.06 (14.54) 9.86 (11.07) 20.03 (23.48) 11.75 (9.79)
Unpleasantness Variability 3.52 (5.61) 2.61 (2.88) 1.87 (4.19) 3.50 (6.42)
Actual repeat numbers used to create the four genotype groups. 
*p < .025
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amount of overall mood change in the lab and higher amounts of PA and NA variability 
were classified as the high affective variability group within their respective variable.
Genetic and hormonal variables were chosen fi-om the screening questionnaire. 
The dichotomous variables that were selected as potential predictors of a genetic 
contribution to emotional variability/reactivity were: personal diagnosis of depression 
(yes/no), family history of depression (yes/no), and family history of bipolar disorder 
(yes/no). Results of the Chi-Square analyses indicated only one significant result. Those 
participants who had a family member diagnosed with depression were more likely to 
exhibit high positive affect variability as measured by the take home daily affect rating 
exercise, (df=  1) = 5.24, p  = .02. Thus, a genetic predisposition toward depression may 
be associated with high PA variability.
Continuous variables that were selected from the screening questionnaire as 
potential hormonal indicators of affect variability/change were: (1) perceived severity of 
pre-menstrual syndrome, (2) perceived severity of oral contraceptive negative mood 
effects, (3) length of menstrual cycle, (4) length of menses, (5) age at first menstruation, 
(6) regularity of menstrual cycle, and (7) history of acne relative to peers. Using two- 
tailed Spearman’s rho correlational tests, (see correlations in Table 9) three interesting 
findings emerged. First, women reporting more severe pms symptoms showed greater 
overall lab mood change (r = .21, p  = .002, A  = 128), and greater NA daily variability 
(r = .35,/? = .005, N=  62). Second, women reporting a history of oral contraceptive 
negative mood change showed a trend toward greater variability in daily PA (r = -.34, 
p  = .046, A  = 35). Third, women with shorter menstruation day lengths experienced a 
trend toward greater variability in daily PA (r = -.27,/? = .038,77= 61). These
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correlations suggest that pms severity, oral contraceptive mood change, and menstruation 
length are potential predictors of affect variability and vice-versa.
Discussion
Summary o f Findings
The first phase of the study examined women’s emotional reactivity in response 
to an anxiety induction procedure, as a function of CAG repeats on the AR gene, TA 
repeats on the ERa gene, and the 16/17 base pair repeat on the 5HTT gene. When the AR 
genotype was examined, women did not differ in terms of their overall lab mood change, 
lab positive (PA) change, or lab negative affect change (NA). The analysis examining 
ERa genotype, however, indicated a trend suggesting that those women who were 
heterozygous for the ERa genotype (s/1) experienced more lab NA change in an anxiety- 
arousing situation. The analysis further revealed a trend indicating that those women who 
were homozygous long (1/1) for the ERa genotype showed more overall lab mood change 
and more PA change than the heterozygous (s/1) and homozygous short (s/s) genotypes. 
Subsequent comparisons of the homozygous (s/s and 1/1) and heterozygous (s/1) 
genotypes served to substantiate the first analysis and indicated trends suggesting that 
homozygotes exhibited a greater amount of overall affect change as well as a greater 
amount of PA change than the heterozygous genotype group, while those women 
heterozygous for the ERa genotype experienced a greater amount of NA change in the 
laboratory. Comparisons of the 5HTT genotypes revealed a trend suggesting that the 
groups differed in PA change. Follow-up ANOVAs revealed that those individuals with 
the 8/10 and 9/10 genotype exhibited an increase in PA while those with the other 
genotypes exhibited a decrease in positive affect. Thus, overall, in response to the mood
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Polymorphic Regions 69
induction, women with the s/1 ERa genotype showed a trend toward greater increases in 
NA, while women with the 1/1 or s/s ERa genotypes exhibited trends toward greater 
decreases in PA as well as greater amounts of overall lab mood change. Also, women 
with the 8/10 and 9/10 genotypes on the 5-HTTgene experienced a greater increase in PA 
in response to the anxiety induction procedure.
The second phase of the study examined whether women’s emotional variability 
(PA, NA, pleasantness and unpleasantness) over the course of the day differed as a 
function of genotype for the three genes. None of these analyses produced significant 
findings, nor were any observable trends present in the data. These results suggest that 
daily mood variability cannot be predicted based on AR, ERa, or 5HTT genotype.
The supplemental analyses examined the ability of self-report genetic and 
hormonal indicator variables to predict emotional reactivity or variability. Examination of 
the genetic variables revealed that women with a relative with a diagnosis of depression 
exhibited greater PA variability throughout the day, compared to those without a family 
history of depression. Correlational analysis between the hormonal variables and the 
indicators of emotional variability revealed three interesting findings. First, women 
reporting more severe pre-menstrual syndrome (PMS) symptoms experienced greater 
overall mood change in response to the anxiety induction (r = .27), and greater daily NA 
variability (r = .35). Second, women reporting a history of greater oral contraceptive 
negative mood change experienced a trend toward greater variability in daily PA 
(r = -.34). Finally, women with a shorter average menstruation duration showed a trend 
toward greater variability in daily PA (r = -.27). These correlations suggest that PMS 
severity, oral contraceptive mood change, and menstruation length are potential
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predictors of affect variability, and that women with greater affect reactivity /variability 
are at increased risk for both PMS and oral contraceptive mood change. Moreover, these 
correlations provide additional evidence that hormones play a role in affective variability. 
Findings for the AR Gene
With regard to the CAG repeat on the AR gene, there was no evidence of an 
effect of genotype on the affect variables assessed in the laboratory anxiety induction 
procedure. Similarly, there was no evidence of an effect of AR genotype on emotional 
variability as measured by the hourly affect rating scales. Very little is known about the 
action of androgens in women. Two studies have linked CAG repeat numbers to 
depression in men (Harkonen et ah, 2003; Seidman et al, 2001). In the case of each of the 
above studies, samples were made up exclusively of men, thus, it is unclear whether any 
of these results can be generalized to women. While the present study did not examine 
depression, the results suggest that affect variability is not related to androgen receptor 
genotype in women.
To test the hypothesis that CAG repeat numbers are linked to depression, scores 
from the SCL-90 depression scale were compared across AR genotype groups using an 
ANOVA. The results of this analysis indicated that CAG repeat numbers were not 
associated with depression scores in women, F {2,109) = 36, p -  .70. Thus, in addition to 
having no effects on emotional reactivity or variability, CAG repeat numbers were not 
associated with depression in the group of women who participated in this study.
Given the findings of the main analyses on the AR gene, as well as the findings of 
the above ANOVA, it is possible that the psychological effects of polymorphisms on the 
AR gene are manifested differently in men and women. Comparisons of allele
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frequencies between our sample and those in the Harkonen et al. (2003) and Seidman et 
al. (2001) studies indicate little difference in AR CAG repeat allele frequency. Most 
frequent in the present study was the 21 CAG repeat allele, accounting for 20.18% of the 
alleles in the sample. This corresponds well with the Harkonen et al. (2003) study in 
which the most frequent allele was also the 21 base pair repeat. Similarly, Seidman et al. 
(2001) reported that 41% of their alleles fell between 21 and 23 repeats. The only notable 
difference between the two groups of men and the group of women used in the present 
study was in the range of alleles. Though similar at the bottom of the range, the studies 
employing male samples reported higher maximum repeat numbers. The repeat numbers 
in the present study ranged from 5 to 28, whereas the repeat numbers in the studies 
employing male participants ranged from 13 to 31 for Harkonen et al. (2003) and 4 to 40 
for Seidman et al. (2001). It is plausible that because women have fewer long alleles of 
the CAG repeat polymorphism, they are less susceptible to androgen-related anxious and 
depressive symptoms. This is supported by the results of Harkonen and colleagues 
(2003), who found that CAG repeat number was positively correlated with depression in 
men (e.g., longer alleles were associated with depression).
In addition, Chamberlain et al. (1994) reported that several human genetic 
diseases have recently been associated with CAG trinucleotide repeat expansion, 
including X-linked spinal and bulbar muscular atrophy (Kennedy's disease), Huntington's 
disease, and spinocerebellar ataxia type 1 (SCAl). Moreover, they report that the size 
range of the repeat in affected individuals is approximately twice the range in the normal 
population. More recent research has indicated that polyglutamine diseases are due to 
CAG repeat expansions. Everett and Wood (2004) state that the polyglutamine disorders
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are the result of a toxic gain of function of mutant expanded proteins. This toxic process 
is characterized by protein misfolding, interference with DNA transcription and RNA 
processing, activation of apoptosis, and dysfunction of cytoplasmic elements, and that the 
end result is apoptotic cell death with many aspects of neuronal function being perturbed. 
Though few studies have been conducted examining psychological disorders and CAG 
repeat numbers, it would appear that more research in this area is warranted given the 
effects of CAG repeat expansion in populations with polyglutamine disorders.
Findings for the ERa Gene
The results of the analyses for the ERa gene provided some support for the 
hypothesis that TA repeat numbers are associated with emotional reactivity in women. 
The findings indicated a trend (p < .03) suggesting that women with different ERa 
genotypes differed with respect to affect change following the laboratory anxiety 
induction procedure. The results suggested that the homozygous (1/1) genotype reacted 
differently than the heterozygous (s/1) genotype with respect to all three dependant 
variables. The homozygous (1/1) genotype group did not show as great an increase in lab 
negative affect change as the heterozygous (s/1) group, yet exhibited a greater amount of 
overall laboratory mood change as well as a greater reduction in lab positive affect 
following the AIP. Additional exploratory analyses comparing the s/1 genotype with a 
combined group of homozygotes (s/s and 1/1) revealed a similar trend indicating that the 
homozygotes exhibited a greater decrease in PA, a greater change in overall lab mood 
change and a smaller amount of NA change than the heterozygous group following the 
AIP.
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The finding that positive affect decreased most and overall lab mood change 
increased most in the homozygous long group is somewhat consistent with the findings 
o f Comings et al. (1999). These researchers found that ERa genotype was significantly 
associated with the anxiety scales of the Symptom Checklist-90, accounting for seven 
percent of the variance in total anxiety scores. They found that there was a progressive 
decrease in the mean anxiety scores fi-om the 1/1 to the s/1 to the s/s ERa genotype groups. 
As the Comings et al. study was conducted using only male participants, the authors 
suggested that because estrogen levels are much higher in women than in men, the 
relationship between the ERa genotype and anxiety may account for the increased 
frequency of anxiety in females. Thus, individuals with the longer alleles experienced 
more anxiety. In the present study, women with the longer alleles showed the greatest 
decrease in PA and the greatest increase in overall affect (made up of fear, sadness, guilt, 
hostility, shyness, fatigue, surprise, joviality, self-assurance, attentiveness, and serenity) 
in response to an MIP designed to induce anxiety. Showing a decrease in PA and increase 
in overall mood may be similar to showing increased anxiety.
In order to test the possibility that women who differ in terms of anxiety before 
or after the MIP also differ on the ERa gene, two one way ANOVAs were performed. 
Both ANOVAs used the genotypes of the women as the IV, with the first ANOVA using 
the pre-BAI score as the DV, and the second using the post-BAI score as the DV. Neither 
the BAI pre score ANOVA, F  (2, 71) = 0.13,/? = .88, nor the BAI post score ANOVA 
were found to be significant, F  (2, 69) = 0.23,/? = .79. This finding indicates that, in our 
sample, women did not differ in level of anxiety as a function of ERa genotype.
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The range and frequencies of alleles in the present study were similar to those in 
the Comings et al. (1999) study, with the 14 repeat allele being the most frequent in their 
study and the 15 repeat allele being most common in the present study. This difference 
did not affect the grouping of long and short alleles. Thus, allele frequencies in the 
Comings et al. study appear similar to those of the women in the present study. However, 
while Comings et al. reported that long ERa alleles are associated with anxiety in men, 
the present study does not suggest this association in women.
The finding that the heterozygous (s/1) genotype group exhibited a greater 
increase in negative affect following the AIP is difficult to explain given what has been 
found in the literature. However, no previous studies have examined affect change with 
respect to ERa genotype. It has been found that longer alleles are associated with anxiety 
(Comings et al., 1999), but that shorter alleles are associated with neuroticism and 
suspicion (Westburg et ah, 2003). Neuroticism, depression and anxiety have shown 
intercorrelations above .55 (Jardine, Martin, & Henderson, 1984).
Thus, it is possible that the heterozygous combination of alleles creates a 
predisposition in which one is more susceptible to negative affect change following 
stressful or anxiety-provoking situations because the long allele predisposes one to 
anxiety and the shorter one to neuroticism and suspicion. This explanation is problematic 
however in that each individual would be susceptible to some variety of psychological 
instability because each possible genotype is associated with some level of dysfunction. 
While it seems illogical from an evolutionary perspective for each genotype combination 
to be associated with dysfunction, regardless of the degree of severity, research on other 
VNTRs have indicated similar patterns (see discussion of the 44 base pair VNTR later).
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Perhaps the TA repeat on the ERa gene acts in concert with other genes to predispose one 
to anxiety, neuroticism, and negative affect change. It may be that all genotype groups 
are associated with some affective dysfunction if and only if another allele on another 
gene is present. Given that the heterozygous group differed from the homozygous groups 
in NA yet there was no pattern indicating that either short or long alleles are dominant or 
recessive, this finding is difficult to interpret. Clearly, this finding needs to be replicated.
Given the present findings, one could speculate that the ERa gene may play a role 
in affect regulation. Future research could examine how this VNTR interacts with other 
genes and the environment to regulate affect. Due to the nature of conflicting findings 
associated with polymorphisms on the ERa gene, further investigation into its role as a 
contributor to psychological dysfunction is warranted in both men and women, not only 
in the case o f emotion and emotional variability and dysregulation, but also in the case of 
anxiety, depression, and personality traits. This research is especially important given the 
number of estrogen-related mood problems women tend to experience over the course of 
their lives (e.g., PMS, menopause, oral contraceptive mood change, and post partum 
depression).
Findings for the 5HTT Gene
Overall, there was no strong evidence that the 16/17 base pair allele on the
serotonin transporter (5HTT) gene was associated with emotional reactivity or variability. 
However, a trend indicated that women with either the 8/10 or 9/10 genotype experienced 
an increase in PA following the MIP, while those women with 10/10, 10/12 and 12/12 
genotypes showed an overall decrease in PA. This trend is worth examining as the effect 
size was quite large and low power likely accounted for the lack of significance. The 8/10
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and 9/10 genotypes are very infrequent and the latter have generally been excluded from 
analyses in previous studies (e.g. Jemej et al., 2004).
It was hypothesized that increases in PA in the combined 8/10-9/10 genotype 
group could perhaps be attributed to actual confidence in their ability with respect to 
three- dimensional visuo-spatial tasks due to their higher ability (i.e. these women may 
have better visuo-spatial ability and therefore show an increase in PA). To test this 
hypothesis, an independent-groups t-test was conducted in which the 8/10-9/10 genotypes 
were combined into one group and compared with all of the other genotypes on their 
Mental Rotations Intelligence Test (MRT) scores. This analysis was not significant, t(97) 
= -1.67, = .76. The mean score on the MRT of the 8/10-9/10 genotype group was 14.67 
(SD = 6.43), while that of the group composed of the remaining genotype was 20.23 (SD 
= 5.65). Thus the 8/10-9/10 genotype group actually performed worse (but not 
significantly so) on the MRT than did those women in the other group.
Because actual visuo-spatial test scores did not account for the Lab PA increase in 
the 8/10-9/10 genotype group, it was then hypothesized that perceived performance could 
have accounted for the increase in Lab PA. In other words, individuals with the 8/10-9/10 
genotype may have performed equally well on the test as those exhibiting the other 
genotypes, however, their perception of their performance may have been better than it 
actually was, thereby increasing their PA from administration one to administration two 
of the PANAS-X. Once again, t-test revealed that this was not the case t(103) = -0.37, p  
=.57. Thus, perceived performance on the MRT test did not account for the increase in 
positive affect after the MRT test in the 8/10-9/10 group.
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Thus, a trend indicated that women with the 8-10-9/10 genotype group exhibited a 
predisposition toward greater PA change. This result must be interpreted with caution 
given that the total number of participants in this group was four. It is not surprising the 
effect was not significant. A sample of four participants generally does not have adequate 
power to produce statistical significance. It is worth noting, however, that both the 8/10 
and the 9/10 genotype occurs very rarely in the population. It has been estimated that the 
nine repeat allele occurs in only one percent of the population, while the eight repeat 
allele has not yet been reported in the literature. Consequently, it would be difficult to 
establish a large group of exclusively 8/10 or 9/10 genotypes.
The trend toward group differences in PA change indicated that the 8/10-9/10 
genotype group differed most notably from those participants with the 12/12 genotype. 
While the 8/10-9/10 women showed an increase in positive affect, the 12/12 women 
exhibited the greatest positive affect decrease following the laboratory anxiety induction 
procedure. This result is somewhat consistent with other studies examining the effects of 
the 5-HTT genotype on affective instability. For example, Ohara et al. (1998) reported 
that the 12 repeat allele was significantly correlated with the risk of anxiety disorders. 
Thus, taken together, the present study and the Ohara study suggest that the 12/12 
genotype predisposes one to anxiety and decreased PA, while the 8/10 and 9/10 
genotypes may protect against the experience of anxiety.
One possible reason for the involvement of the 12 repeat allele in anxiety over the 
other alleles relates to its level of 5-HTT activation. Finkerstrand, Lovejoy, and Quinn 
(1999) found increased reporter gene expression mediated by the 12 repeat allele of the 5- 
HTT gene in embryonic stem cells. Similarly, MacKenzie, and Quinn (1999) found that
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both the 10 and 12 repeat alleles acted as strong and consistent positive transcriptional 
regulatory elements. Moreover, the two alleles were found to differ in the strength of 
their transcriptional-inducing abilities within the developing rostral hindbrain of rat 
embryos. The 12 repeat allele seemed to be significantly stronger than the 10 repeat allele 
(MacKenzie & Quinn, 1999). These findings are supported by data from the same study 
in which additional in vitro data showed that the 12 repeat polymorphism acted as a 
significantly more potent positive regulator of marker gene expression than the 10 repeat 
polymorphism when transformed into embryonic stem cells deprived of leukemia 
inhibitory factor. Their data suggest that the 10 and 12 repeats of the 17 base pair 
polymorphism act as transcriptional regulators and have allele dependent differential 
enhancer-like properties in the embryonic stage of development. Thus, individuals with 
the 12 repeat allele may have higher 5-HTT activity leading to less 5 HT availability in 
the synaptic cleft and increased susceptibility to anxiety.
Certainly, the structure of the 5HTT gene warrants further investigation as several 
different studies have indicated that another VNTR element in the promoter region is 
linked to anxiety. This is known as the 5-HTTPLR region. With regard to this region, 
Ohara and colleagues (1998) found that the 12 repeat allele on the 44 base pair VNTR 
element was associated with anxiety, while Ogilvie et al. (1996) found the 9 repeat allele 
to be associated with anxiety. Similarly, the 10 repeat allele has been associated with 
impulsive, suicidal behaviours, such as those exhibited by individuals with Borderline 
Personality Disorder (Lopez de Lara et al., 2006; Ni et al., 2006). Thus, the role o f the 5- 
HTT gene in anxiety warrants further study.
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As illustrated above, findings with respect to different polymorphisms on 
different areas of the 5-HTT gene are varied and the implications of their effects not 
clear. One approach that may be worthwhile in future studies would involve sequencing 
the whole gene region, as primary protein structure within the VNTR regions may affect 
the regulation of the gene (Snustad & Simmons, 2000). In principle, one or two 
nucleotide changes in a consensus sequence can either specify for a specific transcription 
factor complex or could alter binding affinity (Snustad & Simmons, 2000). Therefore, it 
is conceivable that both the number of repeats comprising the VNTR and the sequence of 
the individual base-pairs within it may be major determinants of VNTR activity 
(Finkerstrand, Lovejoy, & Quinn, 1999). Thus, the VNTR domain can therefore act as a 
transcriptional regulator, a property which could potentially contribute to disease 
susceptibility.
Genetic Predictors o f  Emotional Reactivity
The exploratory analyses examining potential self-report genetic predictors of 
emotional reactivity indicated that having a relative with a diagnosis of depression was 
associated with greater daily positive affect variability. At first, this finding seems 
paradoxical, as one might intuitively expect that having a family history of depression 
would, if anything, predispose one to exhibit a greater amount of negative affect 
variability or lower PA. However, this finding may make sense, given the nature of the 
measure that was used to assess affect. The PA scale of the PANAS is more reflective of 
terms indicating arousal than happiness or excitement. Thus, the label “PA” might not be 
optimal, as the dimension contains a large activation component. The scale does not 
include terms such as happy, content, or at ease. Consequently, if  one employs the
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PANAS as a measure of PA, the absence of pure pleasantness items and the large 
activation component of the scale might account for some unexpected results (Egloff, 
1998). Given that the pleasantness scale used in the present study contains terms that are 
more reflective of happiness and enjoyment rather that arousal, a chi-square test was done 
to examine whether women with and without a family history of depression differ in their 
daily pleasantness variability. There was no significant result. Thus, it may be that 
variability arousal/activation is associated with a history of depression.
Emotions inform the individual of his or her responses to internal or external 
events and are thus considered an important source of information regarding the meaning 
of a given event. Although emotion is generally regarded to have an adaptive function 
within the humanistic/experiential tradition, Misserlian, Toukmanian, Warwar and 
Greenburg (2005) suggest that affect also plays a key role in psychological dysfunction 
by way of underlying maladaptive emotion schemas. Defined as “complex cognitive- 
affective structures [that]. . .store our experienced reactions plus the salient features of the 
situations that elicited the emotions” (Greenberg & Korman, 1993, p. 259), variability in 
emotion schemas are seen to develop out of one’s experiences and interactions with the 
world and serve to inform one’s perception, experiencing, and anticipation of future 
events. Emotion schemas are generally useful for dealing with the world (Greenberg & 
Safi-an, 1987). These schemas provide an efficient means for the individual to save time 
and effort in future perceptual activities. However, they can also be maladaptive when 
they generate emotional reactions that are not congruent with the current situation (e.g., 
they are over-generalized, or misapplied, and, therefore no longer adaptive). Thus, in 
depressed individuals, the sympathetic nervous system might become more easily
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aroused or activated. This arousal may then consequently affect thoughts, behaviours, and 
interpretation of events, leading to depressive symptoms.
Another possible explanation for the link between increased PA and family 
history of depression is an environmental one. That is, individuals with a depressed 
relative may share less PA variability due to the difficulties associated with having a 
depressed relative (e.g., life experiences or family reinforcement patterns). Forbes and 
Dahl (2005) further illustrate how environmental factors associated with PA could lead to 
depression. They do this by relating the criteria for depression with fluctuations in 
positive affect. They begin by stating that depressed mood itself is often experienced or 
expressed as decreased positive affect. Other fundamental characteristics such as 
anhedonia and fatigue are marked by diminished capacities to experience enjoyment and 
diminished motivation and/or decreased energy to pursue enjoyable and goal related 
activities. Social withdrawal, another feature o f depression (but not a criteria), may 
indicate reduced enthusiasm for interactions with others or difficulty obtaining enjoyment 
from those interactions. The authors go on to say that several components of affective 
processes may be disrupted with depression and that many of these components are 
related to positive affect systems. Notably, core aspects o f depression may include any or 
all of the following: reduced motivation to engage in pleasant activities, reduced 
opportunities to experience rewarding situations that generally activate positive emotions, 
difficulty activating positive emotions, and difficulty sustaining positive emotions once 
they are activated. Thus, when one experiences a reduction in PA or when one has a 
tendency to vacillate between high and low levels of PA, one may be more susceptible to 
depression.
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Hormonal Predictors o f  Emotional Variability and Reactivity
An examination of correlations between self-report hormonal variables and 
emotional variability/reactivity revealed three interesting findings. First, women who 
reported more severe pre-menstrual symptoms experienced greater overall lab mood 
change and greater daily NA variability. Second, women reporting a history of worse oral 
contraceptive negative mood change experienced a trend toward greater variability in 
daily PA. Third and finally, women with a shorter menstruation duration experienced a 
trend toward greater variability in daily PA. These correlations suggest that PMS 
severity, oral contraceptive mood change, and length of menstruation are potential 
predictors of affect variability. Furthermore, high daily affect variability may predict risk 
for pre-menstrual mood symptoms and oral contraceptive mood change.
Premenstrual syndrome (PMS) is a cyclical syndrome characterized by mood- 
related and somatic symptoms that occur during the luteal phase o f the menstrual cycle 
and disappear at or soon after the onset of menstruation (Schmidt, Nieman, Danaceau, 
Adams, & Rubinow, 1998). There is no consistent or convincing evidence in the 
literature indicating that PMS is characterized by abnormal circulating plasma levels of 
gonadal steroids, although several studies suggest that levels of estrogen, progesterone, or 
serotonin may correlate with symptom severity in women with PMS (Rubinow, Schmidt, 
& Roca, 1998). Elimination or premature termination of the luteal phase o f the menstrual 
cycle and suppression of ovulation via the use of gonadotropin releasing hormone 
(GNrH) are two of the experimental techniques used to elucidate the effects of gonadal 
hormones on PMS (Rubinow, Schmidt, & Roca, 1998). In the later stages of the luteal 
phase, the level of estrogen increases. At this time, both progesterone and estrogen cause
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the lining of the uterus to thicken in preparation for menstruation. Thus, prior to 
menstruation, there is a fairly high level of estrogen production. Although the elimination 
of the luteal phase has been shown to be effective in relieving symptoms of PMS, two 
studies have demonstrated the return of PMS symptoms in women undergoing these 
treatments (Mortola, 1991; Schmidt et ah, 1998). Rubinow et al. (1998) state that, 
although not a direct cause o f PMS, serotonin may interact with estrogen in the luteal 
phase and aid in conveying a vulnerability to PMS by interacting with changing levels o f 
gonadal steroids.
In an attempt to reconcile the discrepancies of the above studies, Schmidt, 
Nieman, Danaceau, Adams, and Rubinow (1998) conducted a study in which ovulation 
was eliminated using a GNrH treatment in both women who endorsed symptoms of PMS 
and those who did not. After a period of time, the authors re-introduced concentrations of 
estrogen and progesterone in order to determine the effects of each hormone on the onset 
of PMS. The most striking finding of this study was that although women with 
premenstrual syndrome had few symptoms during ovarian suppression and recurrence of 
symptoms during ovarian steroid hormone replacement, the normal women had no 
perturbation of mood during either manipulation. It was concluded that normal plasma 
concentrations of gonadal steroids can trigger an abnormal response in women 
susceptible to PMS. In line with the previous study, Rubinow, Schmidt, and Roca, (1998) 
hypothesize that women with PMS are differentially sensitive to the mood-perturbing 
effects of gonadal steroids, since similar steroid manipulations in women without a 
history of PMS are without effect. Thus, it appears that the differential sensitivity 
hypothesis may be valid given that both women with and without a history of PMS have
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similar levels of circulating gonadal hormones. In the case of the present study, in the 
context of an anxiety-arousing situation, women who experience PMS due to increased 
hormonal sensitivity may also experience greater overall lab mood change and daily NA 
variability. For the same reason, observed connections between hormones and mood 
(e.g., mood symptoms during the premenstrual period) are due to increased hormonal 
sensitivity, the present findings suggest that women who experience more emotional 
variability/reactivity do so because of an increased hormonal sensitivity.
With regard to the second finding of a correlation between PA variability and a 
history of oral contraceptive negative mood effects, Oinonen and Mazmanian (2002), in a 
comprehensive review, outline a number of factors that research has suggested may 
predispose some women to negative mood or affect change during OC use. These factors 
include a history of depression, symptoms of psychological distress, a history of mood 
symptoms related to pregnancy, a family history of OC-related mood symptoms, age, 
being in the postpartum period, and dysmenorrhea and premenstrual mood complaints 
prior to using OCs. A study by Joffe, Cohen, and Harlow (2003) found that a previous 
diagnosis of depression was a significant predictor of OC-related premenstrual mood 
deterioration. Mood improvement was predicted by both dysmenorrhea, and premenstrual 
mood disturbance with an early onset. The above papers provide a substantial amount of 
evidence for hormonal involvement in OC related mood change, as nearly all of the 
predisposing factors for OC negative mood change are biological in nature.
The finding that women with a history of OC-related negative mood change 
experience more variability in PA may seem somewhat paradoxical to individuals who 
tend to think of negative mood as only involving changes in NA. However, as was
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described earlier, this could be reflective of the fact that the PA scale tends to encompass 
items reflecting level of arousal, and women who are more susceptible to negative mood 
side effects may be more predisposed to a greater range of physiological arousal. This 
theory is in line with the differential sensitivity hypothesis put forth by Schmidt et al. 
(1998) in the case of PMS. Furthermore, two other studies have suggested a link between 
OC use and PA variability. Oinonen and Mazmanian (2001) found increased PA 
variability in first time monophasic OC users during the pill-free week. Similarly, 
unpublished findings of Jarva and Oinonen (2006) indicated that OC users experience 
decreased PA variability than non-users in response to four MIPs. Taken together, these 
findings, as well as those of the present study, suggest that the hormones in OCs may 
affect PA variability.
There is very little research examining the effect of menstruation duration on 
affect variability or mood in general. Our correlation suggests that those women with 
shorter menstruation day lengths experience a trend toward greater variability in daily 
PA. One of the only reported studies examining menses duration length and affect was 
that of Levy (1941) who reported that women who displayed more maternal behaviours 
tended to have shorter menstrual day lengths. Those whose menstrual period lasted for 
six or more days viewed themselves as more maternal as defined by play with dolls, role 
most frequently selected in doll play, voluntary mothering in childhood, number of 
children anticipated and general maternal fantasies, general response to babies, 
anticipation of self care, and self-rating on a scale of maternal feeding toward children. 
One other study has linked a longer duration of menstruation to more feminine interests 
and value patterns (Peskin, 1968). Since this time, very little research has been
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conducting in examining behavioural or personality characteristics as a function of 
menstruation duration. Certainly this area of research warrants further investigation. 
Strengths and Limitations o f the Present Study
With regard to strengths, this study is of note primarily because no previous 
studies have examined affect variability or emotional reactivity as a function of genotype. 
Moreover, to increase the likelihood of determining which genes and genotypes are 
linked to emotional variability and reactivity, both an in vitro experimental mood 
induction procedure and an in vivo take home measure was used. No prior studies have 
incorporated both take home, as well as laboratory assessment measures. Though the 
present study offers the previous strengths, it is also not without limitations, among 
which include small groups of participants used in some of the genotype comparisons 
and, possibly, the multiplex fragment analysis used to determine the number of repeats on 
the AR, ERa, and 5-HTT genes.
In the case of nearly all o f the analyses, participant numbers differed across 
groups. The issue of small sample size was especially prevalent in both analyses 
examining the effect of 5-HTT genotype on affective reactivity and variability. Despite 
the fact that the 8/10 and 9/10 5-HTT genotype groups were combined, the sample size 
for the MANOVA examining emotional reactivity in the AIP was only four, while the 
sample size for this cell within the MANOVA examining the effect of 5-HTT genotype 
on daily affective variability was three. In an experiment such as this in which a variable 
is examined as a function of genotype, the problem of small cell size can be difficult to 
circumvent. The 5-HTT gene is a prime example of this as the 9/10 allele is found in only 
1.85% of the population and to date, aside from this study, there has been no known
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report on 8/10 genotype. Thus, assembling a large group of participants falling into each 
of these categories or even a combined category would prove very difficult.
With regard to the genotyping, a multiplex procedure was used to determine the 
number of VNTR base pair repeats for all of the genes of interest at one time. The 
multiplex procedure produced graphical outputs from which the alleles then had to be 
extrapolated via visual analysis. Though the interpretations of these graphs were 
performed by experienced laboratory technicians, a procedure in which each region was 
sequenced individually would perhaps have been more reliable. Such a sequencing 
procedure is planned for the samples employed in this study in the near future.
Another potential limitation with respect to this study is the generalizability o f the 
sample. This sample of women was obtained almost exclusively firom the university 
community and contained educated women between the ages of 19 and 25. It is not 
known whether the results of the present study could be generalized to older women, 
men, or less educated populations. In addition, the genes of the women are not 
homogeneous with respect to ethnicity. Many of the participants in the study indicated 
that they were either first or second generation Canadians with parents or grandparents 
originating from different countries. Women presented with several different ethnic 
backgrounds ranging from all areas of Europe, to Asia, to South America. An ethnically 
heterogeneous sample could pose a problem in that the genes could differ with respect to 
the area of the world in which they originated and may exert different effects on affective 
reactivity and variability.
Three potential limitations relate to the take-home hourly affect surveys. The first 
is concerned with those problems that are typical of studies relying on self-report data. It
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is difficult to know whether the women observed the proper intervals when recording 
their affect. Second, participants did not complete the affect ratings at the same time of 
day, or on the same day. In the future, it may be worthwhile to have all participants 
complete momentary affect ratings at on the same day at the same times. This would 
reduce the likelihood of biases associated with the day of the week or the time of day. For 
example, some individuals chose to complete their affect ratings on a weekend day, while 
others chose to complete their affect ratings during the week. Because some individuals’ 
affect depends largely upon the context in which they find themselves, we may have 
introduced noise into the data by allowing some women to complete the affect ratings on 
a relaxing weekend day rather than a hectic work or school day. Similarly, some 
participants chose to begin their ratings in the afternoon while other chose to begin theirs 
in the morning or early evening. Allowing participants to select their own times to begin 
the affect ratings could have affected PA in that people may have chosen to complete the 
ratings at the time of the day they felt best. Thus, an individual who is happy and content 
in the early hours of the day would perhaps have produced different ratings and 
consequently different variability indices if they were made to complete the affect ratings 
in the evenings. This would also be the case if  a so called “night owl” was made to begin 
completing their ratings at 7 a.m. The third potential limitation relates to the method of 
measuring affect variability. Larsen (1987) highlights a particular problem that may be of 
note when using self report data to monitor affect variability. He indicates that although 
self or other-reported variability is important because it reflects one's own or others' view 
of oneself, it can nonetheless be influenced by judgment bias and might therefore not 
reflect "true" variability of affect. Larsen (1987) goes on to say that while intra-individual
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standard deviations (or variances) are easy to calculate, are face valid, and do not depend 
on restrictive assumptions, they do not reproduce the process of change, and may 
consequently confound the frequency and extremity of change. Therefore, another 
possible way to examine the present data would be to examine whether genotype affects 
one’s affect range as opposed to variability.
A final limitation of the present study concerns a subgroup of women who were 
not included in the analyses. This group consists of women who experienced positive OC 
mood effects. It is possible that this reduced the power of the study design as some 
extreme alleles (i.e., particularly short or long) may have been under-represented. 
Conclusions and Directions fo r  Future Research
This study suggests some directions for future research. There is obviously much 
work to be done in determining the effect of hormonal and monoamine (MA) transporter 
genotypes on affect and affective variability, but also on mood at the clinical level. This 
is particularly the case with respect to the ERa and 5-HTT genes, where strong trends 
indicating differences in affective reactivity between genotype groups were noted using 
conservative alpha levels. These trends may be especially important because they were 
observed in a sample of women that was largely non-clinical with respect to 
psychological functioning.
Future research should be directed at trying to further elucidate the role played by 
the ERa gene in women and its influence on mood and affect-related phenomena. Many 
mood-related phenomena in women have been linked to periods of hormonal fluctuation 
(e.g., menopause, premenstrual phase, postpartum period). Thus, future studies could 
focus on comparing ERa genotypes of women who are depressed or women who have
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had or are currently in the midst of a post-partum episode. Future research could also 
focus on monitoring affect variability/reactivity in non-clinical samples of women across 
the duration of the menstrual cycle, as little research has examined to how factors such as 
cycle length, days of menstruation and age at first menstruation contribute to emotional 
variability.
Studies involving the role of VNTR polymorphisms on mood and affect 
variability should also be carried out in which participants from clinical populations are 
compared to those from non-clinical populations. Of interest would be those clinical 
populations whose hallmark feature is vacillation of affect, such as those with Borderline 
Personality Disorder or Bipolar disorder.
Understanding the contribution of MA and hormonal transporter polymorphisms 
to human behavior, disease susceptibility and response to pharmacotherapies will involve 
further progress in genetic research that will be aided by both the identification of highly 
specific phenotypes and the usage of a large number of polymorphic markers. 
Determination the relationships of genetic polymorphisms to psychological phenomena 
will help clarify the means by which MA transporter and hormonal genetic variability 
contribute to our individuality.
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2. Sex (Circle your answer): male female
3. Please check the box that best describes the highest level of education that you have completed:
[ ] some elementary [ ] completed high school [ ] some university
[ ] completed grade 8 [ ] some college [ ] completed a university degree
[ ] some high school [ ] completed eollege [ ] some graduate studies
[ ] completed a gidduate degree
4. Today’s date:_____________________ _____________
Day of Week (e.g. Monday) Day of Month (e.g. ^ )  Month (e.g. May)
5. Height:_______ (feet & inches) or _______ (cm)
6. Weight: (pounds) o r________(kg)
7. Cheek the box that best describes your current relationship status:
[ ] married or living with partner [ ] one partner, but living apart
[ ] no partner (single) [ ] more than one partner
[ ] casually dating [ ] other:_____________________
8. If  you are currently in a steady relationship, how long have you and your partner been together (in
years and months)?______ years and_______months.
9. If you are currently in a steady relationship, rate your happiness/satisfaction with your current 
romantic partner:
Extremely Unhappy Extremely Happy
or Dissatisfied or Satisfied
1 2 3 4 5 6 7
10. a. Were you raised in Thunder Bay? (circle one) YES NO Part of the Time
b. Were you raised in Northwestern Ontario? (circle one) YES NO Part o f the Time
c. If you were not raised in Northwestern Ontario, was the city/town that you grew up in larger 
in population than Thunder Bay? (circle one) YES NO Same Size
d. Are your biological parents together (married or in a relationship)? (circle one)
YES NO
11. Are you currently taking any medication? (circle one) YES NO
If YES, what medications are you taking? (please list)
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12. Please list any medical or psychological conditions that you have been diagnosed with (e.g. 
hypothyroidism, depression, asthma, cancer, diabetes, etc.)
13. Have you ever been diagnosed with or treated for depression? (circle your answer)
YES NO MAYBE
14. Have you ever been diagnosed with or treated for bipolar disorder or manic depression? (circle your 
answer)
YES NO MAYBE
15. Have you ever been diagnosed or treated for an eating disorder? (circle your answer).
YES NO MAYBE
16. Do you think any of your relatives (i.e. parents, siblings, children, grandparents) have had any mental 
health problems (i.e. depression, anxiety, schizophrenia, alcoholism, eating disorders)? (circle your 
answer) YES NO MAYBE
17. For eaeh of the following, please check the box if you think that one of your biological relatives has 
been diagnosed with or treated for this psychological problem. Also, on the line beside each mental 
health problem, please indicate the relationship of the family member(s) to you (e.g., mother, father, 
sister, grandmother, uncle).
] Depression________
] Personality Disorder 
] Schizophrenia_____
] Anxiety Disorder______________
] Bipolar Disorder/Manic Depression
[ ] Eating Disorder
[ ] Alcoholism___
[ ] Drug Abuse___
[ ] Other:________
18. To the best of your ability, please record your biological parents’ ethnicity and the percentage or 
fraction for each different ethnicity (please leave blank if you do not know the information about your 
biological parents). If you are unsure of the percentages or fractions, simply record the ethnicities.
a)F
b)}
The following two examples are possible ethnic percentages. Use them as guidelines to fill in vour biological
mother and father’s ethnicity in (a) and (b) below these examples.
at Father’s Ethnicitv 1 : Finnish 
Percentage for fi-actioni: 75%
Father’s Ethnicity 3: 
Percentage for fraction):
Father’s Ethnicitv 2: Aboriginal 
Percentage for fraction^; 25%
Father’s Ethnicitv 4: 
Percentage for fraction):
b) Mother’s Ethnicitv 1 : Irish 
Percentage for fraction"): 1/8
Mother’s Ethnicitv 3: Jamaican 
Percentage for fi'action): 1/8
Mother’s Ethnicitv 2; French 
Percentage for fi'action'): 2/8 or 1/4
Mother’s Ethnicitv 4: Scottish 
Percentage for fraction): 4/8 or 1/2






19. Check the box of the statement that best describes you:
[ ] I feel happiest and most productive in the morning hours of the day.
[ ] I feel happiest and most productive in the evening hours of the day.
[ ] I feel equally happy and productive in the morning and evening.
[ ] I feel that none of the above statements apply to me.
20. For each of the following, please check the box if you think that one of your biological relatives 
has been diagnosed with or treated for this medical problem. Also, on the line beside each medical 
problem, please indicate the relationship of the family member(s) to you (e.g., mother, father, sister, 
grandmother, uncle).
] Breast Cancer__
] Ovarian Cancer 





] Other Cancer (Please specify):
] Fertility Problems__________
] Thyroid Disorder (Specify Type if known):
21. This scale consists of a number of words that describe different feelings and emotions. Read each 
item and then mark the appropriate answer in the space next to that word. Indicate to what extent 
you have felt this way today. Use the following scale to record your answers.
1
very slightly 
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22. Current and Recent Alcohol Use (Within the Past 6 months)
a) Currently, how often do you normally consume alcohol? Circle the number under the best answer.
never once or twice once or twice three to four almost
a month or less a week times a week every day
0 1 2 3 4
b) Currently, what is the average number of drinks you have when/if you drink? Circle your answer.
none one to three four to seven eight to twelve more than 12
0 1 2  3 4
c) Currently, how often do you wake up in the morning with a “hangover” due to alcohol use the previous 
night?
never one to three times four to eight eight to twelve most mornings
a month or less times a month times a month
0 1 2  3 4
d) Within the past six months, how many times have you drunk so much alcohol that you vomited? Circle 
the number under the best answer.
never one to three four to seven eight to twelve more than 12 times
0 1 2 3 4
e) Currently, how often do you skip meals when you consume alcohol? Circle the number under the best 
answer.
never 25% of the time 50% of the 75% of the every time
or less time time I drink
0 1 2 3 4
23. Past Use of Alcohol
a) About how old were you when you first took one or more full drinks of alcohol?________
b) About how old were you when you first became intoxicated?_________
c) In the course of one evening, what is the highest number of alcoholic drinks that you have ever consumed? 
________ (# of drinks) (1 drink = 1 beer, 1 glass of wine, or 1.25 ounces of liquor)
How many times have you consumed this many drinks (give best estimate)?______________
d) How many times in your life have you drank so much alcohol that you vomited? (put 0 if  never and 
estimate if unsure of the exact number) ________
e) How many times in your life has your drinking resulted in you having a seizure or convulsions? (put zero 
if  never)_______
f) When you were in the following different age groups, how often did you normally consume alcohol? 
Circle the number that best describes your frequency of alcohol use during that time period. Please leave 
blank the age groups that are older than your current age.




never once or twice 
a month or less
once or twice 
a week




7-8 0 1 2 3 4
9-10 0 1 2 3 4
11-12 0 1 2 3 4
13-14 0 1 2 3 4
15-16 0 1 2 3 4
17-18 0 1 2 3 4
19-20 0 1 2 3 4
21-22 0 1 2 3 4
23-24 0 1 2 3 4
25-26 0 1 2 3 4
27-28 0 1 2 3 4
29-30 0 1 2 3 4
g) When you were in the following different age groups, what was the average number of drinks you had
when/if you drank? Circle the number that best describes your typical consumption of alcohol during that
time period (note that 2 = four to seven and 4= 
older than your current age.
more than 12). Please leave blank the age groups that are
Age
Group
none one to three four to seven eight to twelve more than 12
7-8 0 1 2 3 4
9-10 0 1 2 3 4
11-12 0 1 2 3 4
13-14 0 1 2 3 4
15-16 0 1 2 3 4
17-18 0 1 2 3 4
19-20 0 1 2 3 4
21-22 0 1 2 3 4
23-24 0 1 2 3 4
25-26 0 1 2 3 4
27-28 0 1 2 3 4
29-30 0 1 2 3 4
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h) When you were in the following different age groups, how many times did you drink so much alcohol 
that you vomited? Circle the number under the response that best describes your typical consumption of 
alcohol during that time period (note that 2 = four to seven and 4= more than 12). Please leave blank the age 
groups that are older than your current age.
Age
Group
never one to three 
times/year
four to seven 
times/year
eight to twelve 
times/year
more than 12 
times/year
7-8 0 1 2 3 4
9-10 0 1 2 3 4
Age
Group
never one to three 
times/year
four to seven 
times/year
eight to twelve 
times/year
more than 12 
times/year
11-12 0 1 2 3 4
13-14 0 1 2 3 4
15-16 0 1 2 3 4
17-18 0 1 2 3 4
19-20 0 1 2 3 4
21-22 0 1 2 3 4
23-24 0 1 2 3 4
25-26 0 1 2 3 4
27-28 0 1 2 3 4
29-30 0 1 2 3 4
24. OTHER DRUGS
a) Within the past six months, how often have you typically used recreational/illegal drugs such as marijuana, 
hash, cocaine, LSD, ecstasy, etc.? 
never
0
once or twice 
a month or less 
1
once or twice 
a week 
2
three to four 






b) Approximately how many times have you tried ecstasy? ________ times
c) Approximately how many times have you tried magic mushrooms (psilocybin)?____
d) Check the box that best describes your smoking status:
[ ] never smoked [ ] previous casual/social smoker [ ] previous smoker
[ ] previous smoker [ ] current casual/social smoker [ ] current smoker
e) If you are a current cigarette smoker, how many cigarettes on average do you smoke per day? _
f) If you have ever been a cigarette smoker, how many years did you smoke for?________ years
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25 FAMILY HISTORY
a) Using the following scale, select the number that best describes the current and highest drinking level of 
your biological parents. If your parent is deceased, please leave the current level of drinking blank:
Drinking Levels 
0= I don’t know 
1= nondrinker (abstainer)
2= occasional or light social drinker 
3= moderate or average social drinker 
4= frequent or heavy social drinker 
5= problem drinker 
6= alcoholic
biological mother:
current level of drinking:
biological father:
current level of drinking:
, highest level ever: 
, highest level ever:
b) Do you believe that you have a family history of alcoholism? (Circle answer) Yes No Maybe
c) Have any of your four biological grandparents ever been problem drinkers or alcoholics?
(Circle answer): Yes No Maybe
26. Please answer all of the following questions honestly. For the questions dealing with behaviour, 
write your answers in the blank spaces provided. For the questions dealing with thoughts and 
attitudes, circle the appropriate number on the scales provided.
a) With how many different partners have you had sex (sexual intercourse) within the past year? _____
b) How many different partners do you foresee yourself having sex with during the next five years? (Please 
give a specific, realistic estimate) ______
c) With how many different partners have you had sex on one and only one occasion? ______
d) How often do (did) you fantasize about having sex with someone other than your current (most recent) 
dating partner? (Circle one. If you have not been in a dating relationship then leave this question blank.)
1. Never
2. Once every two or three months
3. Once a month
4. Once every two weeks
5. Once a week
6. A few times each week
7. Nearly every day
8. At least once a day
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f) I can imagine myself being comfortable and enjoying “casual” sex with different partners. 





g) I would have to be closely attached to someone (both emotionally and psychologically) before I could feel 














i) During the past year, with how many different partners have you had only one occasion of sexual contact 
(e.g., hands to genitals, hands to breasts, oral-genital) that did not include sexual intercourse? ______
27. Rate your sexual orientation on the following scale:
I am only attracted 
to people of the 
opposite sex
1 2
I am equally 
attracted to people 
of both sexes 
5 6
I am only attracted 
to people of the 
same sex as me
9
28. Emotions and Personality
a) The following items ask about your attitudes, feelings, and behaviour. Some of the items relate to
food or eating. Other items ask about your feelings about yourself.
For each item, decide if  the item is true about you ALWAYS (A), USUALLY (U), OFTEN (O), 
SOMETIMES (S), RARELY (R) or NEVER (N). Circle the letter in the adjacent column that corresponds to 
your rating. For example, if  your rating for an item is OFTEN, you would circle the O for that item.
Respond to all of the items, making sure that you circle the letter for the rating that is true about you. 
If you need to change an answer, make an “X” though the incorrect letter and then circle the correct one.
A = ALWAYS, U = USUALLY, O = OFTEN, S = SOMETIMES, R = RARELY, N = NEVER
1. 1 e a t sw eets and carbohydrates without feeling nervous. A U 0 S R N
2. 1 think th a t my stom ach is to o  big. A U 0 S R N
3. 1 e a t when 1 am upset. A U 0 S R N
A = ALWAYS, U = USUALLY, O = OFTEN, S = SOMETIMES, R = RARELY, N = NEVER
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4. 1 stuff myself with food. A U 0 s R N
5. 1 think abou t dieting. A U 0 s R N
6. 1 think th a t my th ighs are  too  large. A U 0 s R N
7. 1 feel extremely guilty after overeating. A U 0 s R N
8. 1 think th a t my stom ach is just the  right size. A U 0 s R N
9. 1 am terrified of gaining weight. A U 0 s R N
10. 1 feel satisfied  with th e  sh ap e  of my body. A U 0 s R N
11. 1 exaggerate  or magnify th e  im portance of weight. A U 0 s R N
12. 1 have g o n e  on eating b inges where 1 felt th a t 1 could not stop. A U 0 5 R N
13. 1 like th e  sh ap e  of my buttocks. A U 0 s R N
14. 1 am preoccupied with th e  desire  to  be thinner. A U 0 s R N
15. 1 think abou t bingeing (overeating). A U 0 s R N
16. 1 think my hips are  to o  big. A U 0 s R N
17. 1 e a t m oderately in front of o thers and stuff myself when th ey 're  gone. A U 0 s R N
18. If 1 gain a pound 1 worry th a t 1 will keep gaining. A U 0 s R N
19. 1 have th e  thought of trying to  vomit to  lose weight. A ’• r s R N
20. 1 think th a t my th ighs a re  just the  right size. A Ü 0 s R N
21. 1 think th a t my buttocks are  to o  large. A u 0 s R N
22. 1 e a t o r drink in secrecy. A u 0 s R N
23. 1 think th a t my hips are  ju st th e  right size. A u 0 s R N
b) Please read each of the following statements carefully and circle the one answer that best corresponds to 
your agreement or disagreement. Circle “sd” if the statement is definitely false or if  you strongly disagree. 
Circle “d” if  the statement is mostly false or if  you disagree. Circle “a” if the statement is mostly true or if 
you agree. Circle “sa” if  the statement is definitely true or if you strongly agree. There are no right or 
wrong answers, and you need not be an “expert” to complete this questionnaire. Describe yourself honestly 
and state your opinions as accurately as possible.
SD = strongly disagree, D = disagree, N = neutral, A = agree, SA = strongly agree
1 .1 am not a worrier. sd d n a sa
2 .1 really like most people I meet. sd d n a sa
3 .1 often get angry at the way people treat me. sd d n a sa
4 .1 shy away from crowds of people. sd d n a sa
5 .1 rarely feel lonely or blue. sd d n a sa
6 .1 am dominant, forceful, and assertive. sd d n a sa
7. In dealing with other people, I always dread making a social 
blunder.
sd d n a sa
8 .1 have a leisurely style at work and play. sd d n a sa
9. I rarely overindulge in anything. sd d n a sa
10.1 often crave excitement. sd d n a sa
11.1 often feel hopeless and want someone else to solve my 
problems.
sd d n a sa
12.1 have never literally jumped for joy. sd d n a sa
13.1 am easily frightened. sd d n a sa
14.1 don’t get much pleasure from chatting with people. sd d n a sa
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15. I’m an even-tempered person. sd d n a sa
16.1 like to have a lot of people around me. sd d n a sa
17. Sometimes I feel completely worthless. sd d n a sa
18.1 sometimes fail to assert myself as much as I should. sd d n a sa
19.1 seldom feel self-conscious when I’m around people. sd d n a sa
20. When I do things, I do them vigorously. sd d n a sa
21.1 have trouble resisting my cravings. sd d n a sa
22 .1 wouldn’t enjoy vacationing in Las Vegas. sd d n a sa
23 .1 feel I am capable of coping with most of my problems. sd d n a sa
24 .1 have sometimes experiences unique joy or ecstasy. sd d n a sa
25 .1 rarely feel fearful or anxious. sd d n a sa
26. I’m known as a warm and friendly person. sd d n a sa
27 .1 am known as hot blooded and quick tempered. sd d n a sa
SD -  strongly disagree, D = disagree, N = neutral, A = agree, SA = strongly agree
28 .1 usually pref r tc things alone. sd d n a sa
29 .1 am seldom sad or depressed. sd d n a sa
30 .1 have often been a leader of groups I have belonged to. sd d n a sa
31. At times, I have been so ashamed, I just wanted to hide. sd d n a sa
32. My work is likely to be slow but steady. sd d n a sa
33 .1 have little difficulty resisting temptation. sd d n a sa
34 .1 have sometimes done things just for “kicks” or “thrills.” sd d n a sa
35. When I’m under a great deal of stress, sometimes I feel like 
I’m going to pieces.
sd d n a sa
36 .1 am not a cheerful optimist. sd d n a sa
37 .1 often feel tense and jittery. sd d n a sa
38. Many people think of me as somewhat cold and distant. sd d n a sa
39 .1 am not considered a touchy or temperamental person. sd d n a sa
40 .1 really feel the need for other people iff  am by myself for 
long.
sd d n a sa
41.1 have sometimes experiences a deep sense of guilt of 
sinfulness.
sd d n a sa
42. In meetings, I usually let the others do the talking. sd d n a sa
43. It doesn’t embarrass me too much if people ridicule and tease 
me.
sd d n a sa
44 .1 often feel as if I’m bursting with energy. sd d n a sa
45. When I am having my favourite foods, I tend to eat too much. sd d n a sa
4 6 .1 tend to avoid movies that are shocking or scary. sd d n a sa
47 .1 keep a cool head in emergencies. sd d n a sa
48. Sometimes I bubble with happiness. sd d n a sa
49. I’m seldom apprehensive about the future. sd d n a sa
50.1 really enjoy talking to people. sd d n a sa
51.1 often get disgusted with people I have deal with. sd d n a sa
52 .1 prefer jobs that let me work alone without being bothered by 
other people.
sd d n a sa
53 .1 tend to blame myself when anything goes wrong. sd d n a sa
54. Other people often look to me to make decisions. sd d n a sa
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55 .1 often feel inferior to others. sd d n a sa
56. I’m not as quick and lively as other people. sd d n a sa
57 .1 seldom give into my impulses. sd d n a sa
58 .1 like to be where the action is. sd d n a sa
59. It’s often hard for me to make up my mind. sd d n a sa
6 0 .1 don’t consider myself especially “light hearted.” sd d n a sa
61.1 often worry about things that might go wrong. sd d n a sa
62 .1 find it easy to smile and be outgoing with strangers. sd d n a sa
63. It takes a lot to get me mad. sd d n a sa
64. I’d rather vacation at a popular beach than at an isolated cabin 
in the woods.
sd d n a sa
6 5 .1 have a low opinion of myself. sd d n a sa
6 6 .1 would rather go my own way than be a leader of others. sd d n a sa
6 7 .1 feel comfortable in the presence of my bosses or other 
authorities.
sd d n a sa
6 8 .1 usually seem to be in a hurry. sd d n a sa
6 9 .1 sometimes eat myself sick. sd d n a sa
70 .1 love the excitement of roller coasters. sd d n a sa
71.1 can handle myself pretty well in a crisis. sd d n a sa
72 .1 am a cheerful, high-spirited person. sd d n a sa
73 .1 have fewer fears than most people. sd d n a sa
74 .1 have strong emotional attachments to my friends. sd d n a sa
75. At times I have felt bitter and resentful. sd d n a sa
76. Social gatherings are usually boring to me. sd d n a sa
77. Sometimes things look pretty bleak and hopeless to me. sd d n a sa
78. In conversations, I tend to do most of the talking. sd d n a sa
79. If I have said or done the wrong thing to someone, I can 
hardly bear to face them again.
Sd d n a sa
SD = strongly disagree, D = disagree, N = neutral, A = agree, SA = strongly agree
80. My life is fast paced. sd d n a sa
81. Sometimes I do things on impulse I later forget. sd d n a sa
82 .1 am attracted to bright colours and flashy styles. sd d n a sa
83. When everything seems to be going wrong, I can still make 
good decisions.
sd d n a sa
84 .1 rarely use words like “fantastic!” or “sensational!” to 
describe my experiences.
sd d n a sa
85. Frightening thoughts sometimes come into my head. sd d n a sa
86 .1 take a personal interest in people I work with. sd d n a sa
87. Even minor annoyances can be frustrating to me. sd d n a sa
88 .1 enjoy parties with lots of people. sd d n a sa
89. Too often, when things go wrong, I get discouraged and feel 
like giving up.
sd d n a sa
90.1 don’t find it easy to take charge of a situation. sd d n a sa
91. When people I know do foolish things, I get embarrassed for 
them.
sd d n a sa
92 .1 am a very active person. sd d n a sa
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93.1 am always able to keep my feelings under control. sd d n a sa
9 4 .1 like being part of a crowd at sporting events. sd d n a sa
95. I’m pretty stable emotionally. sd d n a sa
9 6 .1 laugh easily. sd d n a sa
c) Below is a list of problems that people sometimes have. Please read each one carefully, and check the 
box that best describes HOW MUCH THAT PROBLEM HAS DISTRESSED OR BOTHERED YOU 
DURING THE PAST 7 DAYS INCLUDING TODAY.
not at all a little bit moderately quite a bit extremely
Loss of sexual interest or pleasure [ ] [ ] [ ] [ ] [ ]
Feeling low in energy or slowed down [ ] [ ] [ ] [ ] [ ]
Thoughts of ending your life [ ] [ ] [ ] [ ] [ ]
Crying easily [ ] [ ] [ ] [ ] [ ]
Feelings of being trapped or caught [ ] [ ] [ ] [ ] [ ]
Blaming yourself for things [ ] [ ] [ ] [ ] [ ]
Feeling lonely [ ] [ ] [ ] [ ] [ ]
Feeling blue [ ] [ ] [ ] [ ] [ ]
Worrying too much about things [ ] [ ] [ ] [ ] [ ]
Feeling no interest in things [ ] [ ] [ ] [ ] [ ]
Feeling hopeless about the future [ ] [ ] [ ] [ ] [ ]
Feeling everything is an effort [ ] [ ] [ ] [ ] [ ]
Feelings of worthlessness [ ] [ ] [ ] [ ] [ ]
29. Reproductive Questions:
1) a) Have you ever been pregnant? (Only say YES if  you were 100% sure) YES
b) If yes, how many times have you been pregnant? _______
c) How many children have you given birth to? ________
d) How many times have you miscarried? ________
NO
e) How many times have you had an abortion?
f) Are you currently pregnant? (Circle your answer) YES NO MAYBE
g) Some women report experiencing an increase in negative mood, irritability, or weepiness in the 
week or days prior to starting their period each month (during the premenstrual phase). To what 
extent do you experience such negative mood changes prior to your period? (Circle your answer)







quite a bit extremely
2) a) Have you ever taken oral contraceptives? (Circle your answer) YES NO
b) If you have ever taken oral contraceptives, look at the following side effects that some people 
might experience when taking oral contraceptives. Put a check beside any and all of the following 
side effects that you experienced when taking oral contraceptives. Please indicate what oral 
contraceptive brand you were taking when you experienced the side effect. Check all that apply, 
(see question 3f on p. 11 for a list of some oral contraceptive brands)
NauseaW omiting:________
Breast size increase_______
Decreased ability to orgasm _
Weight gain_______ ____







Complete loss of periods___
Heavier periods ( t  bleeding)
Desire to become pregnant_










Painful or tender breasts________
Swelling of breast or abdomen___
Complexion Problems (e.g., acne)
Sexual relationship ended_______
Lighter periods ( i  bleeding)_____
Concerned about hormones
Medical condition (Specify: )
Conflicts with another medication____________
Breakthrough bleeding (bleeding between periods)
c) At what age did you start using oral contraceptives?. _years
d) If you have ever taken oral contraceptives, complete the following:
I believe that oral contraceptives have affected my mood (Circle the best answer)
Very Negatively Slightly Negatively In no way at all 
0 1 2
Slightly positively Very positively 
3 4
e) If you believe that you have ever experienced a change in your mood when taking oral 
contraceptives, check any of the following changes that you noticed in yourself:
Check any of those that apply:
_Slept more than usual 













Cried more than usual
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.Feelings of inferiority  More sensitive to criticism  Cried less than usual
.Disrupted sleep ___ Less sensitive to criticism  More self-eritical
.More content/happy  Less trust in partner (fidelity)  Less self-critical
More Aggressive______ ___ More tnist in partner (fidelity)  Less Aggression
f) Have negative mood side effects ever influenced you to stop taking oral contraceptives? (Circle 
best answer) Yes No Somewhat
g) If you have ever discontinued oral contraceptives due to mood side effects, approximately how 
many days or months did you experienced these negative mood side effects before discontinuing 
use?
________ months and _______ days
h) If you have ever experienced negative mood side effects when taking oral contraceptives, what 
was/were the name of the oral contraceptive(s) that you were taking when you experienced these 
effects? (see list on next page (3g) if you need help remembering the different types)
3) a) Are you currently taking oral contraceptives? (Circle your answer) YES NO
b) If you are currently taking oral contraceptives, for how many years and months have you been 
taking your current oral contraceptive? years and_______ months
c) How long in total have you taken any oral contraceptive?_____ years and_______ months
d) Why did you start taking oral contraceptives? (Check all that apply)
[ ] Birth Control [ ] Treat acne
[ ] For cycle regularity [ ] Other: ____________________
[ ] Due to a hormonal medical condition (Specify): ________________
[ ] I was taking another medication that could have produced birth defects
e) Why are you currently taking oral contraceptives? (Check all that apply)
[ ] Birth Control [ ] Treat acne
[ ] For cycle regularity [ ] Other: ____________________
[ ] Due to a hormonal medical condition (Specify): ________________
[ ] I am currently taking another medication that could produce birth defects
f) If you are currently taking oral contraceptives, please put an X beside the type of oral 
contraceptive you are currently taking.
Alesse_______________  Ortho-Cept ___
Brevicon 0.5/35_______  Ortho 7/7/7
Brevicon 1/35_____ ___  Ortho 10/11
Cyclen___________ ___  Synphasic
Demulen 30_______ ___  Tri-Cyclen
Loestrin__________ ___  Triphasil
Marvelon_________ ___  Triquilar
MinEstrin____________  Demulen 50
Min-Ovral________ ___  Norlestin 1/50
Norinyl______________  Ovral ___







4) a) How many different types/brands of oral contraceptive have you taken? types/brands
b) Please list all of the different types o f oral contraceptives have you used? (Please list all. Refer to 
above list in 3f.)
c) If you have previously taken oral contraceptives but are not taking them right now, how many 
years and months has it been since you last took oral contraceptives?  years and months
d) If you ever stopped a type of oral contracepuve, why did you stop taking that oral contraceptive? 
Check the boxes for all that apply and indicate the oral contraceptive brand that you stopped taking 
due to the side effect (list continued on next page).
Nausea/Vomiting:_________
Breast size increase_______









Complete loss of periods___
Heavier periods (T bleeding)
Desire to become pregnant_










Painful or tender breasts
Swelling of breast or abdomen___
Complexion Problems (e.g., acne)
Sexual relationship ended_______
Lighter periods (\L bleeding)_____
Concerned about hormones
Medical condition (Specify: )
Conflicts with another medication____________
Breakthrough bleeding (bleeding between periods)
Physician recommended discontinuation  _______
Other:
e) Do you have a biological mother or sister who has experienced negative mood effects while taking 
oral contraceptives? (Circle answer): YES NO UNSURE
f) Have you ever taken a contraceptive that contained hormones but that was not oral contraceptives 
(e.g., contraceptive patch, vaginal ring, DepoProvera, hormonal implants, etc.)? (circle answer)
YES NO UNSURE
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5) a) What is the average length of your menstrual cycle right now (i.e., How many days are there from
the first day of one period to the first day of your next period -  most people range between 25 and 
35)?_____________days
b) WTiat is your average length of menstruation/bleeding when you are not taking oral 
contraceptives? (i.e., how many days does your period last? Most people’s periods last between 
1 and 10 days.) _____________days
c) Which statement best describes your menstrual cycle when you are not taking oral 
contraceptives? (Check the box with an “X” beside the appropriate response.)
[ ] I never have my period.
[ ] Some months I get my period and some months I don’t.
[ ] I usually get my period every month, but it is irregular and I cannot predict when it will start.
[ ] I usually get my period within two or three days of when I expect it.
[ ] My period is like clockwork and the same number of days elapse between periods each 
month.
d) How old were you when you first started menstruating (started your period)?  years old
e) As a teenager and young adult, how did/does you acne/pimples compare to your same-age peers?
I had___________acne compared to most girls/women my age (circle the best response).
Significantly Less Slightly Less About the same Slightly More Significantly More
0 1 2 3 4
6) a) Have you ever purposely tried to lose weight? YES NO MAYBE
b) If yes, at what age did you first attempt to lose weight? _______ years
c) At the current time, are you purposely trying to lose weight? (circle your answer)
YES NO MAYBE
d) During the past five years, how much of the time have you been purposely trying to lose weight?
(circle your answer)
Virtually Almost all
never of the time
1 2 3 4 5 6 7 8 9






T his is  a te s t  of your ab ility  to look a t a  draw ing  o f a  g iven  object and find th e  sam e  
object w ith in  a se t  o f  d issim ilar  objects. T he on ly  difference betw een  th e  original object 
and th e  chosen object w ill be th a t th ey  are p resen ted  at different angles. A n illu stra tio n  
o f th is  principle is  g iven  below , w here th e  sa m e sin g le  object is  g iven  in  five d ifferen t 
positions. Look a t each  o f  th em  to  sa tisfy  y o u rse lf  th a t th e y  are only p resen ted  at 
different angles from one another.
B elow  are two draw ings o f n ew  objects . T h ey cannot be m ade to m atch  th e  above five  
draw ings. P lease note th a t you m ay not turn  over the objects. S atisfy  you rself th a t  th ey  
are different from th e above.
N ow  let's do som e sam p le  problem s. For each  problem  there is  a  prim ary object on  th e  
far left. You are to determ in e w h ich  tw o o f  four objects to th e  righ t are th e  sam e object 
given  on th e  far left. In  each  problem  a lw ays tw o  of th e  four draw ings are th e  sam e  
object a s the one on th e  left. You are to  p u tX s  in  the boxes below th e  correct ones, and  
leave  th e  incorrect ones b lank . T he fir st sam p le  problem  is  done for you.
□
Go to  th e  n ext p age
Adapted by S. G. V andenberg, U niversity  o f  Colorado, Ju ly 1 5 ,1 9 7 1
H evised instructions by H . Crawford, U . o f  W yom ing, Septem ber, 1979
Im ages digitized and reprinted by S usan na D ouglas, U niversity  o f Texas, March, 1996
This is a p u b lic  d o m a in  docu m ent a n d  does not require copyrigh t perm ission .
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page 2
Do the rest of the sample problems yourself. Which two drawings of the four on the 
right show the same object as the one on the left? There are always two and only two 
correct answers for each problem. Put an X under the two correct drawings.
2 ,
3.
Answers: 1. first and second drawings are correct
2. first and third drawings are correct
3. second and third drawings are correct
This test has two parts. You will have 3 minutes for each of the two parts. Each p a rt has 
two pages. When you have finished Part I, STOP. Please do not go on to Part 2 until you 
are asked to do so. Remember: There are always two and only two correct answers for 
each item.
Work as quickly as you can without sacrificing accuracy. Your score on this test will 
reflect both the correct and incorrect responses. Therefore, it will not be to your 
advantage to guess unless you have some idea which choice is correct.
DO NOT TURN THIS PAGE UNTIL ASKED TO DO SO.





O  O '  , o  o
5.
o  O ; ; : : :
GO ON TO THE NEXT PAGE
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□ O .. : D
10.
□ □ □
DO NOT TURN THIS PAGE UNTIL ASKED TO DO SO. STOP








□ □ o  . a
14.
□ n . . .  . . o
15.
□ o  o
GO TO THE NEXT PAGE
n □




O  : ; O
17





DO NOT TURN THIS PAGE UNTIL ASKED TO DO SO. STOP
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A) Below is a list of common symptoms of anxiety. Please carefully read each item 
in the list. Indicate how much you are currently bothered by each symptom AT 
THE PRESENT TIME, by placing an X in the corresponding space in the column 
next to each symptom.
Not at all
Mildly
(I am not bothered 
much)
Moderately
(I feel very unpleasant, 
but 1 can handle it)
Severely
(I can barely 
Stand it)
1. Numbness or tingling.
2. Feeling hot.
3. Wobbliness in legs.
4. Unable to relax.
5. Fear o f the worst happening.
6. Dizzy or lightheaded.




11. Feelings of choking.
12. Hands trembling.
13. Shaky.
14. Fear of losing control.
15. Difficulty breathing.
16. Fear of dying.
17. Scared.
18. Indigestion or discomfort in abdomen.
19. Faint.
20. Face Flushed.
21. Sweating (due to heat).
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B) Please indicate how you feel at this moment by circling the appropriate response;




or not at all A Little Moderately Quite a Bit Extremely
1 2 3 4 5
Happy 1 2 3 4 5
Jo )^ l 1 2 3 4 5
Content 1 2 3 4 5
At Ease 1 2 3 4 5
Calm 1 2 3 4 5
Sad 1 2 3 4 5
Blue 1 2 3 4 5
Alone 1 2 3 4 5
Downhearted 1 2 3 4 5
Lonely 1 2 3 4 5
C) This scale consists of a number of words and phrases that describe different
feelings and emotions. Read each item and then mark the appropriate answer in 
the space next to that word. Indicate to what extent you currently feel this way. 
Use the following scale to record your answers:
ver>f slightly 


















































. at ease 
scared 
_ drowsy
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Appendix D
Session #2 Post-Administration Questionnaire
Subject # 
Date:
A) Below is a list of eommon symptoms of anxiety. Please carefully read each item 
in the list. Indicate how much you are currently bothered by each symptom AT 
THE PRESENT TIME, by placing an X in the corresponding space in the column 
next to each symptom.
Not at all
Mildly
(I am not bothered 
much)
Moderately
(I feel very unpleasant, 
but I can handle it)
Severely
(I can barely 
stand it)
1. Numbness or tingling.
2. Feeling hot.
3. Wobbliness in legs.
4. Unable to relax.
5. Fear of the worst happening.
6. Dizzy or lightheaded.




11. Feelings of choking.
12. Hands trembling.
13. Shaky.
14. Fear of losing control.
15. Difficulty breathing.
16. Fear of dying.
17. Scared.
18. Indigestion or discomfort in abdomen.
19. Faint.
20. Face Flushed.
21. Sweating (due to heat).
B) Please indicate how you feel at this moment by circling the appropriate response; 
(1) very slightly or not at all, (2) a little, (3) moderately, (4) quite a bit, (5) 
extremely.
Very Slightly 
or not at all A Little Moderately Quite a Bit Extremely




















































C) This scale consists o f a number o f words and phrases that describe different
feelings and emotions. Read each item and then mark the appropriate answer in 
the space next to that word. Indicate to what extent you currently feel this way. 
Use the following scale to record your answers:
1
very slightly 
or not at all











































.a t ease 
.scared 
.drowsy





















E) What percentage of the items do you think that you answered correctly? %




Attached you will find two packages o f questionnaires. Each package contains 
eight copies of the hourly mood survey. The hourly mood survey is to be completed eight 
times over one 24-hour period, preferably at one-hour intervals. Although completing 
these questionnaires may seem inconvenient at times, we would ask that you adhere as 
strictly as possible to completing them at one hour intervals. For example, if  you begin 
the hourly mood survey at 8:00 am, we would ask that you try to complete the seven 
remaining surveys at 9:00 am, 10:00 am, 11:00 am, 12:00 pm, 1:00 pm, 2:00 pm, and 
lastly at 3:00 pm.
The eighth and final hourly mood questionnaire contains some very brief 
questions concerning events or activities that may have affected your mood over the 
course of the day. We ask that you please complete these at the same time as your final 
hourly mood survey.
In order to facilitate the completion of the questionnaires, we are happy to present 
several tips which may aid you in establishing a schedule that is conducive to completing 
the questionnaires. These include such things as setting a watch or timer at one hour 
intervals, beginning the questionnaires when you get up in the morning, or writing a 
reminder note in a day planner or on a post-it note.
If for some reason you are unable to complete all of the questionnaires in one day, 
we have provided a second package of questionnaires that can be completed on a day that 
is more convenient.
If you have any other questions or concerns, please feel free to contact the 
experimenter, Meghan Richards (mrichar4@lakeheadu.ca) or the research director. Dr. 
Kirsten Oinonen 343-8096, fkoinonen@lakeheadu.caT
Thank you for your time. 
Sincerely,
Meghan Richards
B.A., B.Sc., M.A. Candidate, Clinical Psychology






Please indicate how you are feeling at the present time by circling the appropriate 
response. (1) very slightly or not at all, (2) a little, (3) moderately, (4) quite a bit, (5) 
extremely.
Very Slightly 






























































































































































Please indicate how you are feeling at the present time by eircling the appropriate 
response. (1) very slightly or not at all, (2) a little, (3) moderately, (4) quite a bit, (5) 
extremely.
Very Slightly 
or not at all A Little Moderately Quite a Bit Extremely
Attentive 1 2 3 4 5
Interested 1 2 3 4 5
Alert 1 2 3 4 5
Excited 1 2 3 4 5
Enthusiastic 1 2 3 4 5
Inspired 1 2 3 4 5
Proud 1 2 3 4 5
Determined 1 2 3 4 5
Strong 1 2 3 4 5
Aetive 1 2 3 4 5
Distressed 1 2 3 4 5
Upset 1 2 3 4 5
Guilty 1 2 3 4 5
Scared 1 2 3 4 5
Hostile 1 2 3 4 5
Irritable 1 2 3 4 5
Ashamed 1 2 3 4 5
Nervous 1 2 3 4 5
Jittery 1 2 3 4 5
Afraid 1 2 3 4 5
Happy 1 2 3 4 5
Joyful 1 2 3 4 5
Content 1 2 3 4 5
At Ease 1 2 3 4 5
Calm 1 2 3 4 5
Sad 1 2 3 4 5
Blue 1 2 3 4 5
Alone 1 2 3 4 5
Downhearted 1 2 3 4 5
Lonely 1 2 3 4 5
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Has anything happened during the course of the day that may have affected your mood 
( cither negatively or positively)? Please list all of the events that may apply.
How many hours of sleep did you get last night?
Did you exercise today? Yes No
If yes, what did you do?
Have you taken any drugs/medications today? If so list the amount and the brand.
Did you consume any caffeine today? Yes No
If yes. How much did you drink?
Did you consume any alcohol today? Yes No
If yes. How much did you drink?




This study is being conducted by Dr. Kirsten Oinonen of the Department of 
Psychology at Lakehead University. Portions of this project will be used as Master’s 
theses for Ms. Jessica Bird, and Ms. Meghan Richards. The purpose of the study is to 
examine genetic factors in women’s health. You will receive one bonus point towards 
your Introductory Psychology mark for completing this screening questionnaire. The 
questionnaire will be used to select subjects for one of two studies. Individuals who 
participate in the subsequent studies will receive an additional one or two bonus points 
(depending on which study they are selected for) towards their final mark in Introductory 
Psychology. Please complete the attached bonus point form if  you are in Introductory 
Psychology to ensure that you receive the bonus point.
Your participation in the screening will involve the completion of a questionnaire 
that will take approximately 40 minutes. The questionnaire includes personal questions 
about topics such as; demographic information, health information, medical information, 
reproductive history, relationship information, personalities and mood.
Participation in this experiment is voluntary and you may withdraw at any time 
without explanation and without penalty. All records of your participation will be kept in 
strict confidence and any reports of the study will not identify you as a participant. As 
per university requirements, all data will be stored for seven years by Dr. K. Oinonen at 
Lakehead University and remain anonymous and confidential. Individuals who meet 
specific criteria will be asked to participate in the studies. Therefore, we have asked for 
your name and telephone number on this form (please do not detatch the form). Once we 
have determined who will be asked to participate in the next phase, this sheet will be 
removed from your questionnaire and your information will remain both anonymous and 
confidential. There will be no way that your name can be connected to your responses. 
There are no known physical or psychological risks associated with participating in this 
study. If you have any questions or concerns regarding this study please contact Dr. 
Kirsten Oinonen (343-8096).
I have read and understood the consent form, and I agree to participate in this study 
under these conditions.
Name (Please Print);_________________________Phone Number:
Signature: _________________________________  Date:________




Thank you for participating in the screening phase of our study. The study is
being conducted by Dr. Oinonen, Ms. Richards, and Ms. Bird. Portions of this research
constitute Master’s theses by Ms. Richards and Ms. Bird. If you are selected to
participate in the second part of the study, you will be contacted by one of the researchers
in the next three weeks. Participants in the next phases of the study will receive either
one or two additional points towards their final mark (if they are Psychology 1100
students). If you are chosen for one of the next phases, you will be asked to provide a
DNA sample (oral swab) and complete additional questionnaires.
Please be assured that once participants have been selected for the study, the
consent forms will be removed from the questionnaires and there will be no way to
identity your responses. All of your responses will be coded to conceal your identity on
the questionnaires and all data will remain anonymous. If you have any questions, please
feel free to contact Dr. Oinonen at the contact information below.




Thunder Bay, ON P7B 5E1
(807) 343-8086, koinonen@lakeheadu.ca




Thunder Bay, ON P7B 5E1
jbird@lakeheadu.ca




Thunder Bay, ON P7B 5E1
mrichar4@lakeheadu.ca




I agree to participate in this study that is investigating genetic factors in women’s health.
I understand that my participation is entirely voluntary: I can leave the experiment at any 
time and this will have no bearing on any remuneration I will receive, nor will it have any 
undesirable consequences.
The following points have been explained to me:
1. The purpose of this research is to find out what factors are related to women’s 
health. The benefits I may expect from the study are (a) an appreciation of 
research on health, (b) an opportunity to contribute to scientific research and (c) 
course credit (One bonus point for Introductory Psychology Students).
2. 1 ne procedure will be as follows: During a single session, researchers will obtain 
a DNA sample (via an oral swab) and my body measurements (e.g. height, 
weight, hand measurements) will be taken, 1 will then be required to complete a 
total o f three paper and pencil questionnaires.
3. There are no known serious risks involved in participating in this study.
4. All of the data collected as well as my DNA sample will remain strictly 
confidential. My responses will not be associated with my name. Instead, my data 
will be associated with a code number when the researchers store the data.
5. The experimenter(s) will answer any other questions about the research either 
now or during the course of the experiment (other than specific questions about 
the hypotheses). If 1 have any other questions or concerns, 1 can address them to 
the experimenter(s) Meghan Richards (mrichar4@lakeheadu.ca) or Jessica Bird 
(jbird@lakeheadu.ca) or to the research director. Dr. Kirsten Oinonen 343-8096, 
(koinonen@lakeheadu.ca).
6. Upon completion of my participation, 1 will receive a more detailed written 
explanation about the rationale underlying this experiment.
7. 1 am interested in receiving a summary of the results upon completion of the 
study: yes □  no □
If yes, please indicate your email address:_____________________________
Participant’s Printed Name Signature
Date Experimenter Name
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Appendix J
D ebriefing  Fo rm  B
Principal Investigators: Dr. K. Oinonen, Psychology Department,
Lakehead University,
955 Oliver Road 
Thunder Bay, ON P7E 5E1 
koinonen@lakeheadu.ca, 343-8096
Ms. Meghan Richards, MA Candidate,
Psychology Department 
Lakehead University
955 Oliver Road, Thunder Bay, ON P7E 5E1 
mrichar4@lakeheadu.ca
A/fo Tpçsica Bird, MA Candidate,
Psychology Department 
Lakehead University
955 Oliver Road, Thunder Bay, ON P7E 5E1 
jbird@lakeheadu.ca
We appreciate your participation in our study, and thank you for spending your time to 
help us with our research. When you arrived here you were told that the purpose of this study was 
to investigate genetic factors relating to women’s health. One of the factors in which we are 
interested is how genetic factors are related to mood in young women. In order to examine mood, 
we attempted to induce a negative mood state by telling you that we would be evaluating your 
intelligence based on your performance on a mental rotation test. We want to assure you that this 
test is not a measure of y our intellectual ability.
We misled you about this test because we expected that people may have responded 
differently if they had known the nature of our research questions. We apologize, and hope you 
understand why it was necessary. As you can see, we would not have been able to investigate this 
research question without misleading you regarding the exact purpose of the test. In case you 
have any concerns about your mood and would like to see a mental health professional, we have 
provided you with a list of such resources on the attached sheet.
Given that this study involves some aspects of which you were not fully informed at the 
start, it is very important that you not discuss your experiences with other students until the end of 
the term. If participants have prior knowledge of our specific predictions it would influence their 
results, and the data we collect would be not be useable. Since you will be given a copy of this 
feedback to take home, please do not make it available to other students. If you do not keep this 
form, please dispose of it rather than leaving it somewhere that other students might read it.
Please feel free to discuss with the experimenter any feelings you have about the study right 
away. Should you have further questions, do not hesitate to contact Meghan Richards, Jessica 
Bird, or Dr. Kirsten Oinonen, using the information listed above.
In addition to examining genetic factors involved in mood, we will also be using your 
DNA samples to examine specific genes that are involved in oral contraceptive side effects and 
eating disorder symptomatology. We have included three references on the following page in case 
you are interested in doing further reading relating to the study topics.
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We hope that you have enjoyed participating in our study, and thank you very much for 
your assistance. As noted on the consent form, you will receive a summary o f the results o f the 
study at its completion if  you have indicated an interest.
Mental Health Resource Sheet
Sometimes people can feel upset when thinking about their mood. I f  you feel as 
though you would like to talk to a mental health practitioner for any reason please 




Lakehead University Health and Counseling Centre: 343-8361 
Family Services Thunder Bay: 626-1880 
Catholic Family Development Centre: 345-7323
Emergency services are available at the Thunder Bay Health Sciences Centre 
Thunder Bay Crisis Response (24 hours): 346-8282.
I f  you are interested in doing further reading that is related to this study, here are three
relevant journal articles that you might want to obtain.
Ogilvie, A.D., Battersby, S., Bubb, V. J., Fink, G., Harmar, A. J., Goodwin, G. M. 
&Smith, C. A. D. (1996). Polymorphism in serotonin transporter gene 
associated with susceptibility to major depression. Lancet, 347, 731-733
Oinonen, K., & Mazmanian, D. (2002). To what extent do oral contraceptives influence 
mood and affect? Journal o f Affective Disorders, 70, 229-240.
Wade, T.D., Wilkinson, J., & Ben-Tovim, D. (2003). The genetic epidemiology of body 
attitudes, the attitudinal component of body image in women. Psychological 
Medicine 33, 1395-1405.




1 agree to participate in a study that is investigating genetic factors in women’s health. 1 
understand that my participation is entirely voluntary: 1 can leave the experiment at any 
time and this will have no bearing on any remuneration 1 receive, nor will it have any 
other undesirable consequences.
The following points have been explained to me:
1. The purpose of this research is to find out what genetic factors are related to women’s 
health. The benefits 1 may expect firom the study are: (a) an appreciation of research on 
health, (b) an opportunity to contribute to scientific research, and (c) one bonus point for 
this portion of the study (If 1 am an Introductory Psychology Student).
2. The procedure will be as follows: Over the course of one day within the next week, 1 
will be asked to complete 8 hourly mood surveys using the questionnaires that are 
provided.
3. There are no known serious risks to me for participating in this study.
4. All of the data collected will remain strictly confidential. My responses will not be 
associated with my name; instead, my name will be converted to a code number when the 
researchers store the data.
5. The experimenter will answer any other questions about the research either now or 
during the course of the experiment (other than questions that may reveal the 
hypotheses). If 1 have any other questions or concerns, 1 can address them to the 
experimenters, Meghan Richards and Jessica Bird or to the research director. Dr. K. 
Oinonen.
6. Upon completion of my participation, 1 will receive a more detailed written 
explanation about the rationale underlying this experiment.
Participant’s Printed Name Signature
Experimenter Name Date




Principal Investigators: Dr. K. Oinonen, Psychology Department,
Lakehead University,
955 Oliver Road 
Thunder Bay, ON F7E 5E1 
koinonen@lakeheadu.ca, 343-8096
Ms. Meghan Richards, MA Candidate,
Psychology Department 
Lakehead University
955 Oliver Road, Thunder Bay, ON P7E 5E1 
mrichar4@lakeheadu.ca
Ms. Jessica Bird, MA Candidate,
Psychology Department 
Lakehead University
955 Oliver Road, Thunder Bay, ON P7E 5E1 
jbird@lkaeheadu.ca
We appreciate your participation in our study, and thank you for spending the time 
helping us with our research.
When you agreed to participate in this phase of the study, you were told that the purpose 
of this study was to investigate genetic factors relating to women’s health. In this portion 
of the study, we are more particularly interested in how genetic factors are related to 
mood and mood variability in young women. Thus, we will be using your daily mood 
questionnaires and your DNA sample to determine whether specific genes influence 
women’s mood over the course of the day. In case you have any concerns about your 
mood and would like to see a mental health professional, we have provided you with a 
list of such resources on the back of this sheet. We have also included some references to 
journal articles that are relevant to this study in case you would like to do some further 
reading.
We ask that you not discuss your experiences in the study with any other students who 
potentially could be in this study until after the end of the term. If people come into the 
study knowing about our specific predictions, as you can imagine, it would influence 
their results, and the data we collect would be not be useable. We really appreciate your 
participation, and hope that this has been an interesting experience for you.
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Mental Health Resource Sheet
Sometimes people can feel upset when thinking about their mood. I f  you feel as 
though you would like to talk to a mental health practitioner for any reason please 
consider the resources listed below:
• Lakehead University Health and Counselling Centre: 343-8361
• Family Services Thunder Bay: 626-1880
• Catholic Family Development Centre: 345-7323
• Emergency services are available at the Thunder Bay Health Sciences Centre
• Thunder Bay Crisis Response (24 hours): 346-8282.
I f  you are interested in doing further reading that is related to this study, here are three 
relevant journal articles that you might want to obtain.
Ogilvie, A.D., Battersby, S., Bubb, V. J., Fink, G., Harmar, A. J., Goodwin, G. M. 
Goodwin, G. M., et al. (1996). Polymorphism in serotonin transporter gene 
associated with susceptibility to major depression. Lancet, 347, 731-733
Oinonen, K., & Mazmanian, D. (2002). To what extent do oral contraceptives influence 
mood and affect? Journal o f Affective Disorders, 70, 229-240.
Wade, T.D., Wilkinson, J., Ben-Tovim, D. 2003. The genetic epidemiology of body 
attitudes, the attitudinal component of body image in women. 
Psychological Medicine 33, 1395-1405.




The study that you have just participated in is being conducted by Dr. Kirsten 
Oinonen of the Department of Psychology at Lakehead University, and graduate students 
Ms. Jessica Bird, and Ms. Meghan Richards. The purpose of the study is to examine 
genetic factors in women’s health. Given the valuable time and data that you have 
contributed to this study, we hope to maximally contribute to scientific knowledge with 
this data. If our hypotheses are supported in the current study and/or if there appears to be 
value in conducting a longitudinal follow-up project, we would like to ask for your 
permission to contact you within the next five years, to ask whether you might be willing 
to participate in a follow-up study. Any follow-up study would only be conducted if  it 
had received ethical clearance by the Lakehead University Research Ethics Board and 
any relevant granting agency. Thus, you can be assured that you would only be contacted 
in such a situation. Furthermore, your signature on this form does not constitute your 
consent to participate in a follow-up study. Your signature on this form would only allow 
us the opportunity to attempt to contact you to see if you are interested in participating. If 
we were to receive ethics approval for such a study, we would open up the sealed 
envelope that you would be sealing today. This envelope will contain your name, 
participant number, and contact information (e-mail addresses, telephone numbers, 
addresses). The envelope would only be opened in such a situation, and will be destroyed 
if a follow-up study is not planned within the next five years.
Participation in this portion of the study is voluntary and you may withdraw at 
any time without explanation and without penalty. All records of your participation will 
be kept in strict confidence and any reports of the study will not identify you as a 
participant. As per university requirements, all data will be stored for seven years by Dr. 
K. Oinonen at Lakehead University and remain anonymous and confidential. There are 
no known physical or psychological risks associated with participating in this study. If 
you have any questions or concerns regarding this study please contact Dr. Kirsten 
Oinonen (343-8096).
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FOLLOW-UP STUDY
Please complete the following contact information. This information will only be 
removed from the sealed envelope in the event that a follow-up study has received ethical 
clearance. The information will only be used for the purpose of attempting to contact you 
to determine if  you would like to participate in a follow-up study. Given that it can be 
difficult to know how to contact a person in the future, please feel free to provide any 
additional information that might be of help to us.
Full Name (Please Print):___________________________
Participant Number: _______________________________
E-n.ci. addresses:
Mailing Addresses:   (current)
(home or other)
Telephone Numbers: _______________________________  (current)
_______________________________  (other)
Please fold this paper and place it in the envelope provided and seal the envelope. Please 
write your participant number on the front of the envelope. Thank you for your 
participation.
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